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Abstract 
 
Intestinal Immunity to the Commensal  
Bacterium Akkermansia muciniphila 
By 
Eduardo Ansaldo Gine 
Doctor of Philosophy in Molecular and Cell Biology 
University of California, Berkeley 
Professor Gregory Barton, Chair 
 
Intestinal immunity plays critical roles in maintaining host health. Despite the 
abundance of foreign antigens and activated lymphocytes in the intestine, only a few 
commensal bacteria that induce cognate adaptive immune responses during 
homeostasis have been identified. In this dissertation, I reveal that Akkermansia 
muciniphila, an intestinal bacterium associated with beneficial effects on host 
metabolism and cancer immunotherapy, induces cognate T-dependent immunoglobulin 
G1 (IgG1) and IgA antibody responses and antigen-specific T cell responses during 
homeostasis. In contrast to the select few examples of previously characterized 
mucosal responses to commensal bacteria, T cell responses to A. muciniphila are 
limited to T follicular helper cells in the Peyer’s patches in a gnotobiotic setting, without 
appreciable induction of other T helper fates or migration to the lamina propria. 
However, A. muciniphila-specific responses are context-dependent, and adopt other T 
helper fates in the setting of a conventional microbiota. These findings suggest that 
contextual signals influence T cell immunity to the microbiota and modulate host 
immune function during homeostasis. Interestingly, T cells specific to A. muciniphila 
expand dramatically in a novel (but still uncharacterized) genetic mouse model of 
intestinal inflammation, suggesting that this bacterium may become a major mucosal 
antigen when homeostasis is disrupted. If so, T cell immunity to A. muciniphila may play 
critical roles during infection and inflammatory bowel diseases.  
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Chapter 1: Immunity and the microbiota 
From model antigens to commensal bacteria 
The field of immunology has evolved dramatically from the early days of Élie 
Metchnikoff and Paul Ehrlich and their conceptualization of “cell-mediated immunity” 
and “humoral immunity” (1). Early focus was devoted to the role of T and B lymphocytes 
and their limitless capacity to recognize foreign antigen revealed by the discovery of 
V(D)J recombination. At the time, immune targets were conceived as any epitope not 
encoded in the host genome, and self vs non-self-discrimination was all the 
consequence of tolerance mechanisms applied during lymphocyte development. In fact, 
antigens tended to consist of model, physiologically-irrelevant antigens such as chicken 
ovalbumin (OVA), with the assumption that immune responses to actual pathogens 
would follow the same rules unveiled by the study of these contrived epitopes. Of 
course, the immune system was soon recognized to be more complex than simple 
targeting of any foreign antigen for elimination via T and B lymphocytes: innate immune 
recognition of pathogens was required for the induction of immune responses. 
Recognition of pathogen-associated molecular patterns (PAMPs) by germline-encoded 
pattern recognition receptors (PRRs) was revealed as an initial, required step for the 
induction of immune responses (2), and thus the concept of immunosurveillance 
became a major research focus.  
Since then, the known breadth and complexity of innate and adaptive immune 
cell types and effector functions have dramatically expanded.  In parallel, it is now clear 
that immune cells encompass many aspects of tissue and organ physiology other than 
pathogen recognition and clearance: immune cells participate in cancer surveillance 
and elimination, tissue repair after infection or sterile injury, tissue remodeling during 
development and homeostasis, metabolic tuning etc. It appears that immune cells, 
perhaps due to their ability to circulate, surveil and communicate with other cells, have 
evolved to be intricately tied to tissue function throughout the body. Immune cells are 
thus important players in tissue physiology, acting as “rheostats” that promote a 
homeostatic state that maximizes host fitness.  
One particularly interesting example of the role of the immune system in 
maintaining homeostasis is found at mucosal surfaces. Barrier sites such as the gut, 
skin, oral cavity and vaginal mucosa are colonized with large amounts of commensal 
microbes that are acquired early and persist for the lifespan of the host. Commensal 
microbes provide many beneficial functions to the host. These include colonization 
resistance against pathogens, which is achieved by occupying niches that pathogens 
require for their pathogenesis and outcompeting them (3–7); aid in digestion of dietary 
fiber, which leads to the secretion of metabolites that are both immunomodulatory and 
an energy source (3, 8–10); and education of the immune system, both locally but also 
systemically (3, 11, 12). Furthermore, commensal microbes have been shown to impact 
many areas of host physiology beyond the tissues that they occupy, such as 
metabolism, haematopoiesis, brain function, cancer etc (13). The immune system plays 
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critical roles in establishing a homeostatic state at mucosal surfaces that is conducive to 
all of the aforementioned functions. Immune responses to commensal microbes are still 
an open area of investigation, and in the work presented in this dissertation I will 
describe novel types of commensal-specific responses during homeostasis. 
Commensal microbes pose a conundrum for the classical view of innate 
immunity, since all of these microbes are “foreign” and share the ability to stimulate 
most innate immune receptors with pathogens, yet they don’t elicit similar pro-
inflammatory immune responses at steady state. Part of this conundrum can be 
explained by the fact that pathogens tend to engage in certain activities that 
commensals do not, such as invading systemic tissues, entering the cell cytosol, and 
carefully manipulating the host to evade immune responses. In this view, discrimination 
between commensals and pathogens would follow from these additional activities 
carried by pathogens but not commensal microbes (14).  
However, I would argue that there are additional layers of regulation to immune 
responses to commensal microbes than simply the lack of more invasive activities. The 
important role of the microbiota on many aspects of host physiology, the fact that 
metazoa have coevolved with microbes since their appearance, and the fact that the 
acquisition of an adaptive immune system coincides with the acquisition of a complex 
microbiota, all support the hypothesis that many aspects of the immune system have 
evolved to mediate symbiotic relationships with the microbiota (12). If so, this would 
predict the existence of specific mechanisms of immune sensing and specific immune 
functions tailored to interactions with commensal microbes; perhaps independently, or 
at least parallel to mechanisms for pathogen recognition and clearance. The lack of 
understanding in this area is exemplified by the obscure etiology of Inflammatory bowel 
diseases (IBD), which comprise both Crohn’s disease and Ulcerative colitis, both 
complex diseases of the intestine. IBD are characterized by the induction of 
inappropriate immune responses against the microbiota that lead to immunopathology 
and tissue dysfunction (15), yet the underlying causes and mechanisms are still poorly 
understood. Thus, study of immune system-commensal interactions is likely to yield 
important insights into immune and tissue function during homeostasis and disease.  
The immune system and the microbiota in the intestine 
Many different bacterial communities coexist with mammals. Of those, the most 
well studied, and also the most abundant, is the intestinal microbiota. The intestine is 
colonized by very dense and diverse microbial communities, which reach 1011 bacteria 
per gram of contents in the colon (16). The intestinal microbiota also comprises other 
microbes such as fungi, viruses and protozoa, yet intestinal bacterial communities are 
the most abundant and well-studied. Bacterial load and composition vary from the 
duodenum, the most proximal intestinal tissue, not including the stomach, through the 
jejunum, ileum, cecum, proximal colon and distal colon. Furthermore, bacterial species 
also differ in their localization to the lumen and/or the mucus layer: in the small intestine, 
a loosely-attached mucus layer is permissive to some degree of bacterial colonization, 
while also permitting nutrient absorption. In the colon, a dense inner mucus layer is 
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impenetrable to bacteria and small particles, while the outer mucus layer is less dense 
and hosts bacterial communities (17).  
The large bacterial load found in the intestine poses an important risk to the 
host: bacterial invasion of the underlying tissue or systemic dissemination would have 
disastrous consequences, leading to intestinal tissue dysfunction and septicemia, 
respectively. To prevent this, the immune system, alongside the non-hematopoietic 
intestinal epithelial cell layer, form a mucosal “firewall” that prevents bacterial invasion 
(3, 12, 18, 19). This mucosal barrier is the result of different functions deployed by 
immune and epithelial cells. First, the mucus layer acts as a first physical barrier to 
bacterial invasion. Antimicrobial peptides (AMPs) are constitutively secreted by 
intestinal epithelial cells (IECs), and also by a specialized enterocyte named Paneth 
cell. AMP production, along with other aspects of barrier function, can also be reinforced 
by cytokines derived from innate and adaptive immune cells such as IL-22 and IL-17 
(19–21). Commensal-specific (or “anti-commensal”) IgA antibodies are produced by 
plasma cells in the intestinal lamina propria and are transcytosed through IECs into the 
intestinal lumen by the polymeric immunoglobulin receptor (pIgR). IgA antibodies in the 
intestinal lumen contribute to barrier function by binding to commensal bacteria and 
excluding their targets from deeper invasion into the tissue (22). However, other 
functions of IgA antibodies have been described, such as limiting bacterial motility, 
modulating bacterial gene expression, facilitating niche occupancy in the mucus layer 
and mediating antigen uptake (22–24). Thus, IgA contributes many different functions to 
host-microbiota interactions. Finally, phagocytes in the lamina propria, but also the liver 
(25), engulf and process commensal bacteria that manage to breach the intestinal 
barrier to prevent further dissemination. 
 Of note, many of these functions deployed at steady state are also important 
during tissue challenges such as infection, wounding and/or inflammation. They are 
deployed in parallel to additional measures tailored towards dealing with the specific 
insult and returning to homeostasis. Depending on the insult, these can include 
neutrophil and inflammatory monocyte recruitment (26, 27), induction of high affinity IgA 
antibodies and pro-inflammatory T cell responses towards pathogens (28, 29), induction 
of intestinal epithelial crypt hyperplasia (30), goblet cell hyperplasia (30) and others. 
Immune cells in the intestine lie upstream of all these effector functions: innate and 
adaptive lymphocytes, dendritic cells, and macrophages integrate signals from epithelial 
cells and the environment to direct and coordinate immune responses to maintain, or 
reestablish, homeostasis in the intestine. Much work has been devoted to the study of 
the role of innate immune effector functions in the intestine (21, 31–34). However, 
innate sensing and recognition of the microbiota during homeostasis is only now starting 
to be understood.  
The role of the adaptive immune system is clear in response to intestinal 
pathogens (28, 29). In contrast, much less is known about adaptive immune responses 
to commensal bacteria, both during homeostasis and disease. Even IgA antibody 
responses, which were once thought to have a clear adaptive origin, have now been 
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shown to be largely derived from T-independent B1 innate-like B cells (22, 35, 36). 
Thus, how the adaptive immune system responds to commensal bacteria remains 
largely unexplored. This is of particular importance given the fact that inappropriate T 
cell responses against commensal antigens are thought to underlie disease 
pathogenesis in IBD (15). Therefore, understanding the regulation of adaptive immune 
responses against commensals is likely to yield important insights into host-microbiota 
symbiosis, and could shed light into the mechanisms of this complex set of diseases. 
B cell responses to the microbiota in the intestine 
IgA antibodies play major roles at many mucosal surfaces throughout the body. 
IgA has the ability to dimerize and bind the J chain polypeptide, forming secretory IgA 
(SIgA). SIgA is secreted via interactions with pIgR and transcytosis through epithelial 
cells (22). IgA deficiency is one of the most common human immunodeficiencies (37), 
yet in the absence of IgA, compensatory IgM responses are induced (22). IgM has the 
ability to multimerize into pentamers or hexamers and bind the J-chain, which endows it 
with the ability to be secreted.  
IgA antibodies are secreted into the intestine by plasma cells (PC) present in the 
lamina propria, and are derived from innate B1 and adaptive B2 B cells (22). 
Commensal-specific IgA antibodies are largely comprised of polyreactive, natural 
specificities (36) that are mostly T-independent (35). In contrast, T-dependent antibody 
responses to the microbiota are restricted to a few species, such as segmented 
filamentous bacteria (SFB), Mucispirillum spp., Prevotella spp. and Helicobacter spp. 
(22, 35, 38). There is evidence that some of these commensal bacteria also lead to 
antigen-specific T cell responses (see below), which suggests that they are more 
immunostimulatory and engage distinct arms of the mucosal immune system compared 
to the majority of commensal species.  
Due to an apparent lack of IgG antibodies to commensal bacteria, it was initially 
thought that IgG antibodies did not contribute to intestinal homeostasis (39, 40), and 
that they were only induced in the context of barrier disruption and systemic 
dissemination (39). However, more recent work from my lab has revealed that mice 
generate commensal-specific IgG antibody responses during homeostasis (41). These 
antibodies are comprised of the IgG2b and IgG3 isotypes, are T-independent and 
largely Toll-like Receptor (TLR) 2 and TLR4-dependent. IgG2b and IgG3 antibody 
responses are broadly reactive against commensal bacteria, similar to IgA responses, 
and are thought to originate from similar specificities. IgG2b and IgG3 antibodies do not 
cross into the intestinal lumen like IgA, and can only be detected in the serum of mice, 
yet they play important roles in the neonatal period. Maternally-derived, commensal-
specific antibodies, including IgG2b, IgG3 and IgA, are acquired in the milk and help 
instruct the developing immune system in the intestine by dampening T cell responses 
to the microbiota in the pup (41). Unsurprisingly, IgG antibody responses are also 
induced against intestinal pathogens and pathobionts that breach the intestinal barrier 
and reach systemic sites (28, 42). Finally, IgM+ and IgG+ intestinal plasma cells have 
been detected in humans, and coating of intestinal bacteria by IgM and IgG have also 
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been detected (22, 43), suggesting that similar responses are at play in humans. Of 
note, no role for T-dependent IgG antibody responses to the microbiota has been 
described previously.  
T cell responses to the microbiota in the intestine 
Mucosal surfaces are home to a large number of activated lymphocytes, 
including B-cell derived plasma cells; CD4+ and CD8+  ab T cells, present largely in the 
lamina propria; and gd T cells and other innate-like T cells such as CD8aa T cells and 
others, usually present within the epithelial layer. CD4+ T cells differentiate into one of 
many different fates with different effector functions: T helper 1 (Th1), Th2, Th17, 
regulatory T cell (Treg) and T follicular helper (TFH) cells (44), and each T cell fate 
expresses a lineage-determining transcription factor. Th1 cells express T-bet and 
respond to intracellular pathogens by secreting interferon gamma (IFNg), which 
activates macrophages and fuels inflammation. Th2 cells express GATA3, are induced 
in response to extracellular parasites such as helminths (and also allergens), and 
secrete type-II cytokines such as IL-4, IL-5 and IL-13. These type-II cytokines 
orchestrate many different functions in tissues such as mucus secretion, eosinophil 
recruitment, induction of IgE antibodies etc. Th17 cells express RORgt, are induced at 
mucosal surfaces in response to extracellular bacteria or fungi, and secrete IL-17 and 
IL-22, which help reinforce barrier function and fuel inflammation. T regulatory cells 
(Treg cells) express FOXP3, arise in the thymus by agonist selection on self-antigen, or 
are induced in the periphery in response to innocuous antigens such as food or 
intestinal bacteria (45, 46). Treg cells have an anti-inflammatory role and act as 
negative regulators of immune responses through still poorly understood functions, such 
as secretion of IL-10, sequestration of IL-2 by the high affinity receptor CD25, 
expression of CTLA-4 etc. TFH cells express Bcl6 and are important for the induction of 
T-dependent B cell responses: they help activate naïve B cells, localize to germinal 
centers, provide help to B cells undergoing affinity maturation, and may direct class-
switching through cytokine secretion. Other CD4+ T cell fates, such as Th22 cells (IL-22 
secreting, Th17-like), Th9 cells (IL-9-secreting, Th2-like), and Tr1 cells (IL-10-secreting, 
FOXP3-negative) have also been described in particular contexts (29, 47, 48). 
Given the important role of T cells as orchestrators of immune functions, 
commensal-specific T cell responses are likely to play major roles during both 
homeostasis and disease in the intestine. However, very little is known about the 
induction, regulation and function of commensal-specific T cells in both homeostasis 
and disease. In fact, despite the high abundance of foreign antigens present in the 
intestine and the large number of antigen-experienced T cells present in the lamina 
propria and epithelial layer, only a small number of commensal species have been 
identified that induce cognate T cell responses during homeostasis (12). Thus, 
identification of commensal-specific T cell responses and characterization of their 
functions and regulation remain important goals in the field.  
The number of examples of commensal antigens that induce cognate T cell 
responses are limited to Segmented filamentous bacteria (SFB), Helicobacter spp., and 
  
 
6  
a clostridial flagellar antigen, CBir1. Other bacteria have also been shown to induce 
changes in the intestinal T cell compartment in gnotobiotic settings: namely the 
induction of Treg cells, both in monocolonization experiments (49, 50) and with bacterial 
consortia (46, 51, 52). Human bacteria capable of inducing Th17 cells have also been 
identified (53, 54). Furthermore, ectopic colonization of oral bacteria in the intestine 
induces inappropriate Th1 T cell responses which can drive inflammation in susceptible 
hosts (55). Finally, a defined consortium of human microbes has been shown to induce 
IFNg-producing CD8+ T cells in the intestine, which influenced responses to cancer 
immunotherapy (56). Importantly, in all these other examples, the T cell antigen 
specificity wasn’t identified: while it is indeed possible that the induced T cells are 
cognate to the inducing commensals, it is also possible that they are antigen-specific 
towards other antigens such as bystander commensals, food, or self-antigen. However, 
many of these studies were carried in monocolonized germ-free mice. The presence of 
a single commensal is very artificial, and carries many caveats associated with the 
interpretation of those experiments. Thus, understanding which bacteria induce antigen-
specific T cell responses during homeostasis and in the context of a diverse microbiota 
remains an open question. 
SFB was first identified based on its ability to induce Th17 cells in the small 
intestine lamina propria (SILP) of mice (57, 58). Comparison of genetically identical 
inbred strains of mice from two different vendors, Jackson laboratories and Taconic 
Biosciences, revealed that only mice from Taconic harbor Th17 cells in the SILP at 
steady state. Comparing the microbiota between these mice and performing cohousing 
and microbiota transfer experiments identified SFB as the microbe responsible for the 
induction of Th17 cells (57, 58). Further work revealed that intestinal Th17 cells are 
indeed specific for SFB antigens (59, 60), and that adhesion to epithelial cells by SFB is 
necessary for the induction of Th17 cells (54). While the molecular nature of the signals 
required for the induction of Th17 cells by SFB still remain elusive, one surprising 
observation was that intestinal dendritic cells are largely dispensable for the induction of 
Th17 cells towards SFB, yet CX3CR1+ monocyte-derived intestinal macrophages are 
required (61). Production of IL-17A by Th17 cells is induced by Serum amyloid A 1 and 
2 derived from epithelial cells in the ileum, where SFB is located. SAA production is in 
turn induced by ILC3-derived IL-22. Thus, proinflammatory cytokine secretion by 
commensal-specific Th17 cells is locally regulated by cues derived from multiple cell 
types in the intestine.  
Colonic T regulatory cells are induced by the presence of the microbiota (51, 
62), while Treg cells in the small intestine are induced by dietary antigens (45). Colonic 
T reg cells are largely derived from naïve peripheral T cells, not from thymic-derived 
Tregs (62, 63), suggesting that they are specific for foreign antigens. Regarding the 
signals required for their generation, short chain fatty acids (SCFAs) lead to the 
induction of Treg cells in the colon (8–10). Clostridium species can make SCFA and 
were initially identified as inducers of colonic Treg cells in germ-free colonization 
experiments (51, 52), yet other bacteria and consortia are also able to induce colonic 
Treg cells in gnotobiotic settings (46, 49, 50). Surprisingly, in the context of a complex 
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microbiota, at least a fraction of colonic Treg cells are antigen-specific for Helicobacter 
spp., which is considered a pathobiont (64, 65). Interestingly, a big fraction of colonic 
Treg cells, and most of the Helicobacter-specific ones, coexpress the lineage-
determining transcription factors FOXP3 and RORgt. In IL-10-deficient mice, which lack 
a critical anti-inflammatory cytokine and develop Helicobacter-dependent colitis (66), 
Helicobacter-specific T cells develop into pathogenic Th17 cells instead of RORgt+ Treg 
cells (65). Thus, commensal-specific T cell responses need also be examined in the 
context of a diverse microbiota to avoid caveats associated with monocolonized 
settings.  
Finally, Cbir1 is an antigen derived from a clostridial flagellin that was first 
identified in patients with Crohn’s disease (67). Later work revealed that CBir1-specific 
T cells remain naïve in Wild-type (WT) mice, yet they are activated in mice that lack IgA 
antibodies (68). Furthermore, CBir1-specific T cells also become activated in WT mice 
in the context of acute gastrointestinal infection or chemically-induced intestinal 
inflammation, and adopt CD4+ T cell fates that parallel those induced by the respective 
insult (69). This body of work reveals that one fate of commensal-specific T cells during 
homeostasis is ignorance, or the lack of a response, and that these antigens only lead 
to cognate responses in situations where homeostasis is disturbed. Indeed, given the 
paucity of commensal-specific adaptive B and T cell responses that have been 
identified, it is possible that this is the fate of the majority of commensal antigens, and is 
a general mechanism that prevents inappropriate reactivity to innocuous antigens and 
helps maintain homeostasis.   
T cell responses to commensal bacteria have been hypothesized to provide 
bystander protection against infection (70):  disruption of the intestinal barrier caused by 
an enteric pathogen would lead to concomitant antigen sampling from commensal 
species. Consequently, preexisting commensal-specific T cells could respond to this 
influx of commensal antigens and promote effector functions that are also protective 
against the pathogen. In parallel, T cell responses to commensals are known to underlie 
the etiology of IBD, so dysregulation of existing commensal-specific T cell responses 
would pose a large risk to the host.  
During intestinal infection or inflammation, novel commensal-specific T cell 
responses are induced (CBir1), but homeostatic T cell responses can also adopt 
different fates, such as for Helicobacter spp. in IL-10 deficient mice (65). Given the 
scarcity of examples of commensal-specific responses, it is unclear if one of these two 
scenarios is representative of most commensal-specific responses during disruption of 
homeostasis. Bacteria that are able to induce responses at steady state are more 
immunostimulatory, and may thus be able to dominate responses during inflammation. 
However, some of the most abundant bacteria in the intestine such as Clostridia or 
Bacteroides species appear to be largely ignored by the adaptive immune system 
during homeostasis, but could provide major antigens during barrier disruption due to 
their abundance. I would also hypothesize that the composition of the microbiota, 
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genetic makeup and environmental conditions in the gut are also likely to play important 
roles in determining which bacteria are sensed during homeostasis and disease.  
In conclusion, intestinal adaptive B and T cell responses to commensal bacteria 
are likely to play important roles during homeostasis and disease, yet very few 
examples of commensal-specific responses have been described and little is known 
about the signals required for their induction, their regulation, and their functions. 
Therefore, for my dissertation work I decided to explore antigen-specific adaptive 
immune responses against commensal bacteria. In particular, I decided to explore T-
dependent IgG responses and utilize them to identify immunostimulatory commensal 
bacteria that induce T cell responses during homeostasis.  
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Chapter 2: Commensal bacteria induce T-dependent 
IgG antibody responses during homeostasis 
Many materials in this Chapter have been adapted or reproduced from my 
publication (71): Ansaldo et al. “Akkermansia muciniphila induces intestinal adaptive 
immune responses during homeostasis”, Science, 364, 1179-1184 (2019). Reprinted 
with permission from AAAS. 
Background:  
The discovery of T-independent (TI) commensal-specific IgG antibodies and 
their similar ontogeny and specificity as anti-commensal TI IgA suggested to me that a 
T-dependent (TD) IgG counterpart to commensal-specific TD IgA may also exist. IgG 
antibodies are divided into different isotypes: IgG1, IgG2c, IgG2b and IgG3; which can 
be differentiated based on their constant region. The discovery of a commensal-specific 
IgG isotype that is entirely T-dependent would provide me with an avenue to easily 
identify commensal bacteria that induce cognate adaptive immune responses during 
homeostasis. The rationale is that any bacteria that induces T-dependent IgG 
antibodies is also likely to induce cognate T cell responses, given the requirement for T 
cells. IgA can’t easily be used for the same purpose given that both TI and TD IgA 
specificities coexist within animals. Thus, identifying IgA-bound commensal bacteria is 
insufficient to directly identify bacteria that induce T cell responses, since one cannot 
easily distinguish between TI and TD coating. Even when comparing T cell-deficient 
mice (Tcrb–/–) to WT mice to detect TD coating, this analysis will only reveal commensal 
species that rely strongly on the induction of TD specificities for their coating, and may 
fail to reveal bacteria that can be coated with both TI and TD specificities (35, 38). 
Therefore, existing analysis of T-dependent IgA binding to commensal bacteria are 
likely to miss important targets of adaptive immune responses.  
Commensal-specific antibodies have been implicated in many aspects of host-
microbiota symbiosis. Maternally-transmitted antibodies help dampen intestinal T cell 
responses to commensal bacteria in the neonatal period (41), and also contribute to 
neonatal intestinal immune development by transferring microbial molecules to the pup 
in utero, increasing innate lymphoid cell 3 (ILC3) and mononuclear cell numbers in the 
intestine (72). Furthermore, systemic commensal-specific antibodies have been shown 
to protect against gut-derived septicemia during intestinal barrier disruption (42, 73, 74). 
However, pathogenic roles for commensal-specific antibodies have also been 
described: increased commensal-specific IgG is a hallmark of patients with Ulcerative 
colitis (UC), where IgG antibodies contribute to disease in genetically susceptible 
people and mice through activation of IgG receptors (FcgR) on intestinal macrophages 
(75). Thus, just like with commensal-specific T cell responses, it appears that antibody 
responses to commensal bacteria underlie both mutualistic and pathogenic aspects of 
host-microbiota symbiosis.  
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T-independent anti-commensal antibody responses are comprised of low-affinity 
polyreactive specificities (36). Given their ability to recognize broad fractions of 
commensals, TI antibodies are likely to contribute to some of the important roles 
outlined above. High-affinity TD IgA antibodies are only induced against select 
members of the microbiota (35, 38), and TD IgG anti-commensal antibodies haven’t 
been previously described before this work. However, I would argue that due to their 
high affinity, and their highly selective specificities, these are likely to play important 
roles in the functions outlined above, as well as new roles. Indeed, AID-dependent, 
SFB-specific IgA antibodies, which are T-dependent (35), have been shown to be 
important to contain SFB in the mucosa and prevent inflammation (76). Thus, 
delineating which commensal species induce high affinity T-dependent antibody 
responses is likely to unveil important host-commensal interactions.  
In summary, I hypothesized that a T-dependent arm of the commensal-specific 
IgG antibody response exists. To test this hypothesis, I decided to explore commensal-
specific responses of all IgG isotypes and compare T cell deficient and T cell sufficient 
mice. Identification of an IgG isotype that is entirely T-dependent would allow me to 
identify commensal bacteria that induce cognate T cell responses and are likely to play 
important roles during homeostasis and disease.  
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Results: 
To examine commensal-specific T-dependent IgG antibody responses, I utilized 
a previously-described method to detect serum IgG specificities capable of binding to 
the intestinal bacterial microbiota (41). I collected paired mouse serum (containing 
antibodies) and feces (containing intestinal microbes), and stained preparations of fecal 
bacteria with serum antibodies. I then used secondary antibodies against specific 
mouse IgG isotypes, IgG1, IgG2c, IgG3 and IgG2b, to probe binding to the microbiota 
by performing flow cytometry (Figure 2.1A). Flow cytometry is a single-cell assay that 
reads out fluorescence on multiple, predetermined channels for each individual cell, and 
allows for analysis of large number of events per second, up to 10,000/s. Sybr-green I 
and side scatter allowed for the discrimination of bacteria from small food particles. 
Biotinylated secondary antibodies specific for IgG isotypes and fluorophore-conjugated 
streptavidin allowed for the detection of IgG-bound bacteria. Finally, B-cell deficient 
mouse sera (Ighm–/–) served as a negative control that lacks all antibodies in the serum. 
I compared serum binding to commensal bacteria in WT and T cell-deficient 
(Tcrb–/–) mice to determine whether T-dependent IgG antibody responses against 
commensals are induced at homeostasis. Surprisingly, this analysis revealed that mice 
mount a microbiota-reactive IgG1 antibody response that is entirely dependent on T 
cells (Figure 2.1A, B), while anti-commensal IgG2b, IgG3 and IgA are induced in a T-
independent manner as previously reported (Figure 2.2A) (35, 41, 77). Importantly, 
Ighm–/– serum has only minimal binding to the fecal microbiota. The small amount of 
remaining staining with the Ighm–/– serum is likely due to nonspecific binding of the 
streptavidin-PE-Cy7 secondary fluorophore used in the assay, since it is still present 
when the secondary IgG-specific biotinylated antibody is omitted from the assay (Data 
not shown). The fraction of commensals bound by T-dependent IgG1 was 
approximately 10% (Figure 2.1B), far less than the percentage recognized by IgG2b, 
IgG3 and IgA (Figure 2.2A). This relatively small percentage suggested that mice 
produce IgG1 that recognizes only a subset of microbes in the intestine, in contrast to 
the polyreactive T-independent antibodies that bind diverse bacteria (36, 41).  
The microbiota composition of mice from different sources or even different lines 
of mice housed in the same facility can vary significantly (13, 58), and mouse genetic 
background and microbiota composition have been linked to differences in the anti-
commensal IgA response (78, 79). Cohoused littermate mice are critical controls in 
phenotypes affected by the microbiome, as they allow for the discrimination between 
genetic and microbiome contributions to a given phenotype (13). Thus, to rule out the 
possibility that the different phenotypes observed in WT and Tcrb–/– mice were due to 
different microbiota composition, and not due to the lack of T cells in Tcrb–/– mice, I 
analyzed T cell-sufficient (Tcrb+/–) and T cell-deficient (Tcrb–/–) cohoused littermates and 
again observed an anti-commensal IgG1 response only in T cell-sufficient mice (Figure 
2.2B). Moreover, analysis of mice from multiple vendors and of different genetic 
backgrounds revealed that this IgG1 response is a general feature of healthy mice 
(Figure 2.1C).  
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To identify the commensal species targeted by serum IgG1 antibodies, I 
adapted a previously-described assay that identified fecal bacteria bound by IgA, IgA-
Seq (35, 38). In this assay, I stained fecal bacteria with serum from corresponding mice 
and secondary antibodies for IgG1 as described above, and then performed 
fluorescence activated cell sorting (FACS) to isolate IgG1-bound bacteria and IgG1-
negative bacteria. Importantly, this assay differs from IgA-Seq in that it uses serum to 
provide antibody binding to the bacteria, and thus probes systemic antibody 
specificities. Then, I performed 16S rDNA (ribosomal DNA) sequencing on the resulting 
fractions. 16S rDNA sequencing amplifies a small hypervariable region within the 16S 
ribosomal RNA gene from bacteria, such as region V4, and then performs next-
generation sequencing on the PCR product library. After paired-end sequence 
alignment and filtering, the resulting 250bp reads are then clustered to OTUs 
(operational taxonomic units) with clusters of 97% DNA sequence identity. This step 
allows to reduce noise from sequencing errors, and bins together strains of the same 
species with very similar 16S sequences.  
  I sorted IgG1-bound and unbound populations from fecal samples stained with 
sera from corresponding mice (Figure 2.3A, B) and performed 16S rDNA sequencing on 
the resulting fractions (IgG1-Seq). Two Operational Taxonomic Units (OTUs) were 
significantly enriched in the IgG1-positive fractions compared to the IgG1-negative 
fractions (Figure 2.1D and Figure 2.3C, D). These OTUs correspond to the 
Akkermansia genus (OTU2) and the Bacteroides S24-7 family (OTU63). Bacteroides 
S24-7 consists of an uncultured and poorly characterized family of mouse intestinal 
microbes (80, 81). Akkermansia is a genus of intestinal commensals in the 
Verrucomicrobia phylum that until recently only contained one member, Akkermansia 
muciniphila (82, 83) . Performing IgG1-Seq on other cohorts of mice also identified 
Akkermansia muciniphila and Bacteroides S24-7 as targets of IgG1 antibodies (Figure 
2.4A). Importantly, only specific OTUs assigned to the Bacteroides S24-7 family were 
recognized by IgG1, while many others remained in the left part of the volcano plot in 
Figure 2.1D and Figures 2.4A and B. Given the lack of characterization of this bacterial 
family, it is likely that only individual genera or species within Bacteroides S24-7 induce 
IgG1 responses, while many others do not.  
At least one cohort had a different major target pertaining to the Faecalibacullum 
genus, and targeting of Akkermansia and Bacteroides S24-7 was still present, but 
weaker (Figure 2.4B). Importantly, the same Faecalibacullum OTU was clearly IgG1-
negative in a parallel cohort of mice (Figure 2.4A), suggesting that it may not be a 
common target of IgG1 antibodies across mice with different bacterial communities.  
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Discussion: 
Commensal-specific TD antibodies were previously thought to be restricted to 
IgA responses specific for a small subset of commensal species (22). My work reveals 
that such TD antibodies also include IgG antibodies, in particular IgG1. While T-
independent IgG isotypes (IgG2b and IgG3) are broadly reactive against a large fraction 
of the microbiota (41), IgG1 responses are much more restricted to a small number of 
commensal bacteria. These bacteria include Akkermansia and specific members of the 
Bacteroides S24-7 family, but can also include additional bacteria in certain cohorts.  
IgG1-targeted bacteria may share certain features, such as proximity to the 
intestinal epithelium, which may increase their potential to cause disease during barrier 
disruption. Thus, preemptive induction of high affinity systemic antibodies against them 
could help protect in the event of barrier disruption and systemic access of these 
bacteria. Indeed, systemic antibodies specific for commensal bacteria have been 
reported to protect against gut-derived septicemia (42, 74), although a role for 
microbiota-specific TD IgG specificities wasn’t explored. Furthermore, Akkermansia 
muciniphila can promote disease in certain immunodeficient settings (84), which 
supports the hypothesis that IgG1-targeted bacteria are immunostimulatory and may 
contribute to disease pathogenesis in the context of immune dysregulation or systemic 
access. TD commensal-specific IgG1 responses are likely to contribute to other 
functions in addition to protection against systemic dissemination. IgG antibodies are 
transmitted in utero and in the milk, and they help instruct the neonatal immune system 
and protect against enteric pathogens (41, 72, 85), while also driving intestinal disease 
in genetically susceptible settings (75). Commensal-specific IgG1 antibodies are likely 
to contribute to these effects. In fact, I would argue that given their specificity and 
affinity, IgG1 antibodies could play dominant or non-redundant roles in the 
aforementioned functions. 
 Finally, bacteria that induce T-dependent IgG1 antibody responses are likely 
to induce cognate T cell responses during homeostasis. Given the scarcity of examples 
of commensal-specific T cell responses and the important roles that T cells play during 
homeostasis and disease in the gut (12), identifying T cell-inducing commensal bacteria 
gives me an opportunity to gain important insights in this understudied area.  
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Methods: 
Animals: 
Mice were housed under specific-pathogen-free (SPF) or gnotobiotic conditions 
at UC Berkeley. Mice in Figure 2.1C were analyzed upon arrival from the indicated 
vendors. For SPF experiments, adult (8-16 weeks of age, male and female) C57BL/6J 
mice were used as wild-type mice. Congenic C57BL/6J.SJL (B6.SJL-Ptprca Pepcb/BoyJ) 
mice were also included as wild-type mice for one of the repeats in Figure 2.1D. Mice in 
Figure 2.1D comprised two consecutive litters (two cohorts of littermate mice) born to 
the same breeding cage. All experiments were performed in accordance with the Animal 
Care and Use Committee guidelines at the University of California Berkeley.  
Microbiota/bacterial flow cytometry and sorting: 
Microbiota flow cytometry was performed as previously described (41). Briefly, 
fresh fecal pellets and blood were collected from individual mice. Blood was centrifuged 
at 13,000×g for 15 min twice to collect serum. Fecal pellets were homogenized in 1mL 
phosphate-buffered saline (PBS) and filtered through a 40-µm filter, centrifuged at 
10,000×g for 3 min and washed in PBS. Optical density (OD) was measured and an OD 
1=109 bacteria/mL approximation was used for all samples.  
Fecal samples were stained overnight at 2.5x107 bacteria/mL in 50µL of 
bacterial staining buffer (BSB) (1%BSA in PBS + 0.025%NaN) with serum added at 
1:50 final dilution factor (unless otherwise noted) in a V-bottom 96-well plate. For 
microbiota flow cytometry, feces and sera originated from the same mouse, except 
when otherwise noted. Samples were washed with 150 µL of BSB, pelleted (3,220×g 5 
min 4ºC) and resuspended in BSB with secondary antibodies. Biotinylated secondary 
antibodies were used at 1:200: anti-mouse IgG1 A85-1 (BD Pharmigen), anti-mouse 
IgG2a 5.7 (BD Pharmigen), anti-mouse IgG3 R40-82 (BD Pharmigen), and polyclonal 
anti-mouse IgA (1040-08 Southern Biotech). After washing and pelleting, samples were 
resuspended in BSB + Streptavidin-PE-Cy7 (SA-PE-Cy7) (Invitrogen) at 1:200. 
Samples were washed with BSB and resuspended in 200 µL BSB with Sybr-green I 
nucleic acid stain (Invitrogen) at 1:10,000. Samples were analyzed on a BD LSR 
Fortessa or a BD LSR Fortessa X-20.  
 For sorting of IgG1-bound commensals, 4x106 bacteria (assuming OD 1=109 
bacteria/mL) were stained overnight in 4 mL with 80 µL of serum (1:50 dilution) in BSB. 
After pelleting (10,000×g 3 min 4ºC) samples were washed in BSB, pelleted and 
resuspended in 1 mL BSB with secondary anti-mouse IgG1-biotin for 30min at 4C. BSB 
was added to wash, samples were pelleted and resuspended in 1 mL BSB with SA-PE-
Cy7 for 25 min at 4ºC, pelleted, washed with BSB, pelleted and resuspended in 3 mL 
BSB (with SYBR Green 1:10,000). Samples were sorted into IgG1+ and IgG1– fractions 
on a BD FACSAria Fusion sorter. 1x106 IgG1+ and 2x106 IgG1– events were collected, 
and input and sorted fractions were pelleted, resuspended in 100 µL of PBS and frozen 
at -80ºC prior to sample processing.  
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16S rDNA sequencing and analysis: 
 Sample processing and 16S rDNA sequencing were performed at the Alkek 
Center for Metagenomics and Microbiome Research at Baylor College of Medicine. 
Sample processing was performed with a DNeasy PowerSoil kit (QIAGEN). V4 16S 
rDNA sequencing was conducted on a MiSeq (Illumina) with 2×250 paired-end reads.  
Sequence processing was performed using Mothur 1.39.5 according to the 
MiSeq SOP protocol (86), using the 128 release of the SILVA ribosomal RNA database 
(87). Operational taxonomic units (OTUs) were clustered to 97% identity. Rare OTUs 
with two sequences or fewer, OTUs that were not present in at least 25% of the 
samples and OTUs that were less than 0.01% of total sequences were removed. Paired 
ratio Student’s t-tests (Paired Student’s t-test on log-transformed data) were calculated 
using scipy.stats in Python 3.7, and Benjamini, Krieger and Yekutieli’s two-stage false 
discovery rate (FDR) approach was used to correct for multiple comparisons, with an 
FDR (Q) of 0.01, using statsmodels.stats in Python 3.7.  
Quantification and statistical analysis: 
 Statistical tests were performed as indicated on the figure legends with Prism 8 
software (Graphpad Prism). Statistical analysis of 16S rDNA sequencing data was 
performed as indicated above.  
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Figures: 
 
Figure 2.1. Mice generate anti-commensal IgG1 antibodies during homeostasis 
(A) Representative IgG1 flow cytometric analysis of fecal microbiota with sera from WT 
and T cell-deficient (Tcrb–/–) mice. Feces and sera originated from the same mouse 
(paired serum), except when using antibody-deficient (Ighm–/–) serum as a negative 
staining control. SYBR-green labels a fraction of the microbiota, ensuring that SYBRhi 
events are bacteria, whereas some of the SYBRlo events are also commensals that are 
less permeable to the dye (41). 
(B) IgG1 microbiota flow cytometric analysis, compiled from eight independent 
experiments. All mice were housed at UC Berkeley. WT n=63, Tcrb–/– n=35 in total. 
(C) IgG1 microbiota flow cytometric analysis with paired feces and sera from mice of the 
indicated genetic backgrounds and vivaria. Balb/c from Jackson Laboratories. Jax B6 
and Tac B6: C57BL/6 from Jackson Laboratories or Taconic Biosciences, respectively. 
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SW: Swiss Webster from Taconic Biosciences. n=5 mice per group. Data are 
representative of two independent experiments.  
(D) Results from sorting and 16S rDNA sequencing of IgG1-bound and unbound 
fractions (n=12 mice). Graph depicts the average log2 ratio of abundances between 
both fractions for each individual OTU and the corresponding q-value. Data are 
representative of two independent experiments. 
Each symbol represents a mouse (B, C) or an OTU (D). Error bars represent mean ± 
SD. Gates on flow cytometry plots show mean±SEM. p-values were calculated by a 
Kruskal–Wallis test followed by Dunn’s multiple comparisons (B) or by Paired ratio 
Student’s t-test followed by Benjamini, Krieger and Yekutieli’s two-stage false discovery 
rate (FDR) to correct for multiple comparisons, with an FDR (Q) of 0.01 (D). 
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Figure 2.2. Anti-commensal IgG1 antibodies, but not other isotypes, are T cell-
dependent 
(A) Microbiota flow cytometric analysis of WT and T cell deficient (Tcrb–/–) mice 
comparing different antibody isotypes. Data are representative of two independent 
experiments. WT n=8, Tcrb–/– n=8.  
(B) IgG1 microbiota flow cytometric analysis of Tcrb+/– and Tcrb–/– littermate mice that 
were kept cohoused upon weaning. Data are compiled from four independent 
experiments. Tcrb+/– n=18, Tcrb–/– n=16 in total.  
(C) IgG1 microbiota flow cytometric analysis of WT and Tcrb–/– mice. WT and Tcrb–/– 
feces were stained with paired sera, and sera from Tcrb–/– and WT mice, respectively, to 
show the presence of IgG1-inducing bacteria in the Tcrb–/– microbiota. n=13 WT mice, 
n=15 Tcrb–/– mice. Data are representative of three independent experiments.  
Each symbol represents a mouse, error bars represent mean ± SD. p-values were 
calculated by Multiple t-tests with Holm–Sidak correction (A) or a Kruskal–Wallis test 
followed by Dunn’s multiple comparisons (B and C). 
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Figure 2.3. Supporting data for sorting and 16S rDNA sequencing of IgG1-bound 
and unbound bacteria 
(A) Representative IgG1 microbiota flow cytometric analysis pre- and post-flow 
cytometric sorting.  
(B) Frequencies of IgG1-bound bacteria in the indicated fractions, n=12 mice.  
(C) 16S rDNA sequencing abundances in the three fractions for OTU0002 
Akkermansia. n=12 mice.  
(D) 16S rDNA sequencing abundances in the three fractions for OTU0063 Bacteroides 
S24-7, n=12 mice. 
All data are representative of two independent experiments. Each symbol represents a 
mouse, error bars represent mean ± SD. Gates on flow cytometry plots show 
mean±SEM. p-values were calculated with a one-way ANOVA followed by Tukey’s 
corrected multiple comparisons. 
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Figure 2.4. Additional IgG1-Seq experiments confirm targeting of Akkermansia 
and Bacteroides S24-7 
(A and B) Results from sorting and 16S rDNA sequencing of IgG1-bound and unbound 
fractions. n=6 mice (A) or 7 mice (B). Graph depict the average log2 ratio of 
abundances between both fractions for each individual OTU and the corresponding q-
value. Data are representative of two independent experiments. 
Each symbol represents an OTU. p-values were calculated by Paired ratio Student’s t-
tests followed by Benjamini, Krieger and Yekutieli’s two-stage false discovery rate 
(FDR) to correct for multiple comparisons, with an FDR (Q) of 0.05. 
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Chapter 3: A. muciniphila induces cognate IgG1 
antibody responses in conventional and gnotobiotic 
mice 
Many materials in this Chapter have been adapted or reproduced from my 
publication (71): Ansaldo et al. “Akkermansia muciniphila induces intestinal adaptive 
immune responses during homeostasis”, Science, 364, 1179-1184 (2019). Reprinted 
with permission from AAAS. 
Background: 
Of the two major targets of IgG1 antibodies that I identified, only Akkermansia 
was amenable to further study: Bacteroides S24-7 contains many different 
uncharacterized taxa (80), all of which were uncultured at the time of this work. A few 
members of the S24-7 family have been cultured recently, but this family contains at 
least 685 species detected by sequencing, including the type strain Muribacullum 
intestinalis (88, 89). This bacterial family has been renamed to Muribaculaceae after its 
first cultured member. Because my IgG1-Seq analysis identified many Bacteroides S24-
7 taxa that were not targeted by IgG1 antibodies (Figure 2.1D), isolating and culturing 
the IgG1-targeted OTU may still remain challenging today.  
In contrast, Akkermansia is a culturable genus of intestinal commensals in the 
Verrucomicrobia phylum that until recently only contained one species, Akkermansia 
muciniphila (82). A second species of Akkermansia, Akkermansia glycanyiphila, was 
recently isolated from pythons (83). A. muciniphila was first isolated from human feces 
based on its ability to utilize mucin as a sole carbon and nitrogen source (82), which 
also serves as selective media to culture and obtain A. muciniphila isolates.  A. 
muciniphila is an abundant member of the human intestinal microbiota (90). The 
genome of A. muciniphila has been sequenced, and probing full 16S rDNA sequences 
from human individuals (91), as well as more recent sequencing and culturing efforts 
(unpublished communications), have revealed that different Akkermansia species and 
strains exist in humans.  
After its initial characterization, subsequent studies revealed that A. muciniphila 
exerts diverse effects on the host: First, it was shown that A. muciniphila has protective 
effects in diet-induced obesity (92), and also appears to underlie the protective effects 
of interferon gamma (IFN	g) deficiency on glucose metabolism (93). Further studies 
explored outer membrane proteins in Akkermansia (94), and focused on an individual 
protein that appears to be sufficient to improve metabolism in diabetic mice (95). A 
proof-of-concept clinical trial has been conducted with positive results utilizing daily oral 
A. muciniphila supplementation to improve type-II diabetes in humans (96). Recent 
studies have also shown that A. muciniphila and its metabolites may influence 
Amyotrophic Lateral Sclerosis (97). 
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Akkermansia muciniphila has also been shown to localize and bloom in wound 
beds in the intestine during wound healing (98). Here, A. muciniphila takes advantage of 
oxygen depletion and Muc3 secretion at the wound bed to rapidly expand at this site, 
and then enhances enterocyte proliferation and migration in a FPR1/NOX-1-dependent 
manner, which contributes to wound healing. Furthermore, A. muciniphila colonization is 
increased in a ketogenic diet, which in turn confers protection against seizures in mouse 
models of epilepsy (99). Finally, A .muciniphila abundance has been associated with 
improved responses to anti-PD-1 cancer immunotherapy (100). In this study, patients 
with evidence of systemic type-I T cell responses to A. muciniphila responded better 
than patients without such responses. A. muciniphila-mediated improvements in anti-
PD-1 cancer immunotherapy were recapitulated in mouse models, although the 
mechanism of protection was not elucidated.  
The mechanisms by which A. muciniphila mediates these diverse effects remain 
poorly understood, as little is known about host sensing of this bacterium. However, 
these observations show that A. muciniphila is playing active roles in modulating host 
physiology, and many of these effects appeared to involve immune components, 
suggesting that this commensal species interacts closely with the immune system. 
Based on my observations that A. muciniphila induces TD IgG1 responses, and based 
on its reported effects on host physiology, I hypothesized that understanding 
homeostatic immune responses to this commensal bacterium could reveal novel 
aspects of immune system-microbiota interactions and shed light into the mechanisms 
of the aforementioned physiological effects. Therefore, I sought to characterize the 
immune response to A. muciniphila.  
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Results: 
In order to validate the results obtained by IgG1-Seq, first I isolated A. 
muciniphila from mice the colony by plating feces on selective media that contains 
mucin as the only carbon and nitrogen source (82). This yielded an A. muciniphila 
isolate with a 16S rDNA gene identical to the type strain ATCC BAA-835 first isolated 
from humans (82). I then used bacterial flow cytometric analysis to confirm the presence 
of A. muciniphila-specific IgG1 antibodies in the sera of mice that harbored A. 
muciniphila at steady state (Figure 3.1A), thus validating that A. muciniphila is a target 
of serum IgG1 antibodies.  
IgA antibodies consist predominantly of natural, polyreactive specificities (101). 
Thus, binding to any given commensal bacterium by IgA is not dependent on previous 
encounter with that specific species. Anti-commensal IgG2b and IgG3 are also 
comprised of broadly-reactive specificities (41), as they probably share a similar 
ontogeny to IgA responses. IgG1 antibody responses to A. muciniphila could consist of 
pre-existing natural polyreactive specificities or antigen-specific responses. Given the T-
dependent nature of the anti-commensal IgG1 response, I hypothesized that A. 
muciniphila-specific IgG1 antibodies would be comprised of specific, high affinity 
responses, which would predict that previous colonization with A. muciniphila would be 
required for the induction of the cognate IgG1 response. To test this hypothesis, I 
identified C57BL/6 mice lacking A. muciniphila in their microbiota (Figure 3.1B) from a 
specific room in Jackson laboratories (a mouse vendor). Comparing IgG1 antibody 
responses between A. muciniphila-negative and A. muciniphila-positive mice confirmed 
that the induction of A. muciniphila-specific serum IgG1 responses required colonization 
with A. muciniphila, as well as T cells (Figure 3.1A-C and Figure 3.2A). A. muciniphila-
positive mice also mounted serum A. muciniphila-specific TD IgA responses (Figure 
3.2B). Moreover, de novo colonization of A. muciniphila-negative mice by oral gavage 
was sufficient to induce A. muciniphila-specific IgG1 antibodies (Figure 3.1D-F and 
Figure 3.2C). Thus, IgG1 responses to A. muciniphila are not derived from pre-existing 
cross-reactive specificities. Rather, mice mount an antigen-specific TD IgG1 antibody 
response upon A. muciniphila colonization. 
Gnotobiotic mice are generated by colonizing germ-free mice with specific 
bacteria, and are then maintained and bred in a gnotobiotic isolator. Microbial 
communities tend to be very stable in gnotobiotic mice once they have achieved 
equilibrium, and the axenic conditions of gnotobiotic isolators prevent contamination 
with additional environmental microbes. This reductionist approach allows investigators 
to carefully control microbiota composition and test the role of individual variables, such 
as the addition of a single species, without additional changes in microbiota composition 
that are hard to avoid in specific-pathogen-free (SPF, or conventional) mice.  
I noted that titers of serum IgG1 responses against A. muciniphila were variable 
across A. muciniphila-positive mice. A small number of mice lacked A. muciniphila-
specific IgG1 altogether, despite similar colonization (Figure 3.1B, C and Figure 3.2A). 
One explanation for this variability is that variation within intestinal microbial 
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communities may alter the response to A. muciniphila. Indeed, previous studies have 
shown that intestinal infection or inflammation can lead to altered bystander responses 
against commensal microbes (69). To overcome such complications, I established a 
defined gnotobiotic system to examine whether direct engagement of the mucosal 
immune system by A. muciniphila underlies the TD IgG1 response. I introduced A. 
muciniphila into gnotobiotic C57BL/6 mice colonized with altered Schaedler flora (ASF) 
(102) to generate two mouse colonies with identical microbiota, except for the presence 
of A. muciniphila in the ASF+Akk colony. The altered Schaedler flora is a consortium of 
eight mouse intestinal microbes, including six obligate anaerobes. The ASF 
recapitulates many of the features of a conventional microbiota, such as the induction of 
colonic Treg cells and intestinal IgA (46), and thus avoids many of the caveats 
associated with germ-free mice, including their underdeveloped immune systems.  
 A. muciniphila colonized ASF+Akk mice to high levels and was vertically 
transmitted (Figure 3.1G, and Figure 3.2D). In order to study homeostatic responses 
and avoid potential caveats associated with oral gavage of bacteria, I restricted all of my 
analyses to descendants of ASF+Akk mice that acquired A. muciniphila via vertical 
transmission. Mice colonized with the ASF+Akk flora, but not the ASF flora alone, 
mounted IgG1 responses specific for A. muciniphila which, in contrast to conventional 
mice, had very consistent titers between mice (Figure 3.1H, I). Importantly, I also 
observed very robust serum IgA binding to A. muciniphila in ASF+Akk mice. 
Interestingly, ASF mice showed a small amount of IgA binding, perhaps resulting from 
polyreactive T-independent IgA specificities present in the serum. Thus, A. muciniphila 
directly engages the immune system to induce TD IgG1 and IgA. 
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Discussion: 
The work described in this chapter reveals that A. muciniphila is both necessary 
and sufficient to induce cognate IgG1 antibodies in mice. In contrast to polyreactive 
specificities characteristic of T-independent isotypes (101), IgG1 antibodies to A. 
muciniphila require previous colonization with this commensal. Antibody titers to A. 
muciniphila were rather variable in conventional (SPF) mice, suggesting that complex 
interactions with other commensal microbes or environmental variables that differ 
between mice in my colony are at play.  
Mucosal infection or inflammation (69), as well as barrier disruption (39) have 
been shown to induce ectopic adaptive immune responses to commensal microbes. 
Thus, it was formally possible that A. muciniphila was being targeted by systemic TD 
antibodies as a direct consequence of ongoing (and variable) infection or inflammation 
in my mouse colony, and not due to direct engagement of the immune system by A. 
muciniphila at homeostasis. De novo colonization of A. muciniphila-free mice is 
sufficient to induce a response, which partially addresses this concern. Finally, 
gnotobiotic ASF+Akk mice, which are not exposed to pathogens from the environment, 
induce very robust and consistent antibody responses to A. muciniphila, which 
definitively shows that Akkermanisa is actively engaging the intestinal immune system 
at homeostasis.  
Interestingly, A. muciniphila also induced high titers of specific IgA antibodies 
both in SPF and gnotobiotic conditions, which were partially T-dependent, suggesting a 
broader immune response to this commensal bacterium. The dependency on T cells, as 
well as the robust binding observed argue that IgG1 and IgA responses to A. 
muciniphila are comprised of high-affinity antibodies. This is in contrast to the majority of 
the commensal microbiota, which is only targeted by T-independent low-affinity IgA 
(22). Only a few commensal species are targeted by T-dependent IgA (35, 38), 
including now A. muciniphila.  
Given that systemic antibodies have been implicated in protection against gut-
derived septicemia (42, 73, 74), high affinity antibodies against select 
immunostimulatory members of the commensal microbiota may provide enhanced 
protection against systemic dissemination of these specific bacteria during barrier 
disruption. These bacteria appear to all colonize niches close to the intestinal 
epithelium: SFB attaches to epithelial cells in the terminal ileum, and A. muciniphila and 
Mucispirillum spp. both reside in the intestinal mucus layer. Colonization of these niches 
may be interpreted by the immune system as having increased potential to invasion and 
dissemination, and thus the induction of high affinity local (IgA) and systemic (IgG) 
antibodies may be a preemptive strategy to deal with the possibility of dissemination. In 
support of this hypothesis, high levels of A. muciniphila can drive inflammatory disease 
in immunodeficient settings (84).  
In contrast, commensal-specific antibodies are increased during inflammatory 
bowel disease (75, 103), and commensal flagellin appears to be an immunodominant 
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epitope for antibodies and T cells in patients with IBD (104). Furthermore, 
polymorphisms in a receptor for IgG antibodies, FcgRIIA, are implicated in ulcerative 
colitis, where IgG antibodies can drive Th17 immunity and disease (75). Thus, pre-
existing high affinity antibodies to the commensal microbiota, such as for A. muciniphila, 
may be detrimental in genetically susceptible people.  
Finally, commensal-specific antibodies have been implicated in neonatal (41), 
as well as in utero education of the immune system (72). High affinity TD antibody 
responses to select immunostimulatory commensals may help educate the early 
immune system and prevent dysregulated responses against these immunostimulatory 
bacteria that could otherwise drive intestinal disease.  
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Methods: 
Animals: 
Mice were housed under specific-pathogen-free (SPF) or gnotobiotic conditions 
at UC Berkeley. For SPF experiments, adult (8-16 weeks of age, male and female) 
C57BL/6J mice were used as wild-type mice. All experiments were performed in 
accordance with the Animal Care and Use Committee guidelines at the University of 
California Berkeley. For gnotobiotic experiments, gnotobiotic C57BL/6NTac mice 
colonized with altered Schaedler’s flora were obtained from Taconic Biosciences and 
imported into the gnotobiotic facility at the University of California Berkeley. ASF and 
ASF+Akk mouse colonies were maintained in separate flexible film isolators (Class 
Biologically Clean). ASF+Akk mice were generated from C57BL/6NTac ASF mice by 
two oral gavages of 109 cfu of Akkermansia muciniphila (colony isolate) 2 days apart. 
Colonization with A. muciniphila was tested by 16S A. muciniphila fecal qPCR and 
absence of contaminants was routinely tested by bacterial plating and fecal 16S rDNA 
sequencing. For experiments including ASF+Akk mice, I analyzed progeny (or progeny 
of progeny) of A. muciniphila-gavaged mice.  
 A. muciniphila-positive and A. muciniphila-negative C57BL/6J mouse 
colonies were kept and bred under SPF conditions. A. muciniphila-positive mice were 
already present in my colony at the University of California Berkeley. A. muciniphila-
negative mice were initially obtained from Jackson Laboratories, room RB08 (for 
experiments in Figures 3.1 and 3.2). I also determined that a 3-week course of 
tetracycline hydrochloride in the drinking water (3 g/L tetracycline hydrochloride, 1% 
sucrose, pH=7, changed every 3 days) was sufficient to clear mice of A. muciniphila.  
Isolation and culture of A. muciniphila: 
A. muciniphia was isolated from mice in my SPF colony by plating mouse feces 
on selective media. Briefly, serial dilutions of homogenized fecal samples in PBS were 
plated on mucin plates in an anaerobic chamber (COY). Mucin plate composition: 0.4 
g/L KH2PO4, 0.53 g/L Na2HPO4, 0.3 g/L NH4Cl, 0.3 g/L NaCl, 0.1 g/L MgCL2·6H2O, 0.15 
g/L CaCl2·2H2O, 4 g/L NaHCO3, 0.5 g/L L-Cys·HCl·H2O, 2.5 g/L Type III hog gastric 
mucin (Sigma), 3mL/L trace mineral solution (ATCC), 0.75 mg/L resazurin, pH=6.5, 7.5 
g/L agar, autoclaved for 15 min. The full 16S rRNA gene of the obtained isolate was 
amplified using universal 16S primers (27F and 1492R), sequenced, and revealed to be 
identical to the 16S rRNA gene for the type strain A. muciniphila ATCC BAA-835. 
Liquid cultures of A. muciniphila for oral gavage were grown in brain heart 
infusion (BHI) + 2.5g/L Type-III hog gastric mucin and 0.5g/L L-Cys·HCl·H2O in an 
anaerobic chamber (COY). 36-48-h cultures were harvested, centrifuged at 10,000×g 
for 3 min and resuspended in anaerobic PBS (PBS + L-Cys·HCl·H2O, pH=7).  
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Fecal A. muciniphila 16S qPCR: 
DNA was isolated from fecal samples using the QIAamp DNA Stool Minikit or 
QIAamp Fast DNA Stool Minikit (Qiagen) according to manufacturer’s instructions. 
Homogenization was performed on a Mini Beadbeater (BioSpec products) for 2 min. 
Quantitative PCR was performed on a StepOnePlus thermocycler (Applied Biosystems) 
with SsoAdvanced universal SYBR green supermix (Bio-RAD). The 16S gene from A. 
muciniphila was PCR-amplified using 16S primers 27F (5ʹ-
AGAGTTTGATCMTGGCTCAG-3ʹ) and AmucR-V1 (5ʹ- CCTTGCGGTTGGCTTCAGAT -
3ʹ), cloned into a pCR-BluntII TOPO vector (Invitrogen), and then linearized with the 
restriction enzyme BamHI. This linearized vector was used to generate standard curves 
for qPCR (included on each qPCR plate). Primers were synthesized by Integrated DNA 
Technologies. One of two different pairs of A. muciniphila-specific primers were used 
(with same results):  
A.muciniphila-F V1: 5ʹ-CAGCACGTGAAGGTGGGGAC-3ʹ.  
A.muciniphila-R V1: 5ʹ-CCTTGCGGTTGGCTTCAGAT-3ʹ.  
A.muciniphila-F V2: 5ʹ-AGTATCGAAAGATTAAAGCAGCAATGC-3ʹ.  
A.muciniphila-R V2: 5ʹ-TCTTGTGGTACTATCTTTTTAATTTGCT-3ʹ. 
Fecal DNA samples were diluted to a range with a proportional relationship 
between dilution and CT value (usually 1:40) and the resulting CT value was used to 
calculate the concentration of A. muciniphila 16S gene copies using the standard curve. 
The amount of recovered 16S gene copies was normalized to the input fecal material 
(weight), and after applying the appropriate dilution factors, a factor of 3 copies/genome 
was used to calculate genome equivalents per gram of feces (based on the genome 
sequence for ATCC BAA-835 A. muciniphila strain). 
Bacterial flow cytometry: 
A 36-48-h culture of A. muciniphila was grown in brain heart infusion (BHI) + 
2.5g/L Type-III hog gastric mucin (Sigma) and 0.5g/L L-Cys·HCl·H2O in an anaerobic 
chamber (COY). Bacterial cultures were stained overnight at 2.5x107 bacteria/mL in 
50µL of bacterial staining buffer (BSB) (1%BSA in PBS + 0.025%NaN) with serum 
added at 1:50 final dilution factor (unless otherwise noted) in a V-bottom 96-well plate. 
Samples were washed with 150 µL of BSB, pelleted (3,220×g 5 min 4ºC) and 
resuspended in BSB with secondary antibodies. Biotinylated secondary antibodies were 
used at 1:200: anti-mouse IgG1 A85-1 (BD Pharmigen), and polyclonal anti-mouse IgA 
(1040-08 Southern Biotech). After washing and pelleting, samples were resuspended in 
BSB + Streptavidin-PE-Cy7 (SA-PE-Cy7) (Invitrogen) at 1:200. Samples were washed 
with BSB and resuspended in 200 µL BSB with Sybr-green I nucleic acid stain 
(Invitrogen) at 1:10,000. Samples were analyzed on a BD LSR Fortessa or a BD LSR 
Fortessa X-20.  
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Figures: 
 
Figure 3.1 Akkermansia muciniphila is necessary and sufficient to induce cognate 
A. muciniphila-specific IgG1 antibody responses 
(A) Representative IgG1 bacterial flow cytometric analysis of A. muciniphila incubated 
with the indicated mouse sera. Applies to results shown in C. 
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(B) Quantification of A. muciniphila colonization by fecal 16S qPCR for mice in (C).  
(C) A. muciniphila IgG1 bacterial flow cytometric analysis for mice of the indicated 
genotypes and indicated A. muciniphila colonization status. WT Akk– n=25, WT Akk+ 
n=41, Tcrb–/– n=15. gMFI: geometric mean fluorescence intensity. Data are compiled 
from seven independent experiments. 
(D) Quantification of A. muciniphila colonization by fecal 16S qPCR before (WT Akk–) 
and 5 weeks after (WT Akk-colonized) a single A. muciniphila oral gavage of 109 cfu. 
n=6 mice. Applies to results shown in F. Data are representative of three independent 
experiments.  
(E, F) Representative plot (E) and quantification (F) of A. muciniphila IgG1 bacterial flow 
cytometric analysis using sera from mice before (Akk–) and 5 weeks after colonization 
(Akk-colonized). n=5 mice. Data are representative of three independent experiments.  
(G) Quantification of A. muciniphila colonization by fecal 16S qPCR. n=6 ASF, n=16 
ASF+Akk mice. Data are representative of two independent experiments.   
(H and I) A. muciniphila bacterial flow cytometric analysis with serial dilution of serum in 
ASF and ASF+Akk mice. Each line represents one mouse. The x-axis denotes total 
serum IgG1 (H) or serum IgA (I) concentration in the assay. n=9 mice per group. Data 
are representative of two independent experiments.  
LoD: limit of detection. Each symbol represents a mouse, error bars represent mean ± 
SD. p-values were calculated with a Kruskal–Wallis test followed by Dunn’s multiple 
comparisons (B, C) or a Mann–Whitney test (D, F, G).   
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Figure 3.2 A. muciniphila induces antigen-specific IgG1 and IgA antibody 
responses in SPF and gnotobiotic mice 
(A) A. muciniphila IgG1 bacterial flow cytometric analysis with serial dilution of serum 
from WT Akk+ (n=30 mice), WT Akk– (n=12 mice), and Tcrb–/– (n=16 mice). Each line 
represents one mouse. The x-axis denotes total serum IgG1 in the assay. Data are 
representative of two independent experiments.  
(B) A. muciniphila bacterial flow cytometric analysis for serum IgA antibodies. WT Akk– 
n=19, WT Akk+ n=40, Tcrb–/– n=27. gMFI: geometric mean fluorescence intensity. Data 
are compiled from two independent experiments. Each symbol represents a mouse, 
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error bars represent mean ± SD. p-values were calculated with a Kruskal–Wallis test 
followed by Dunn’s multiple comparisons. 
(C) Experimental design for de novo colonization with A. muciniphila. Applies to results 
shown in Fig. 2 D-F. 
(D) Schematic of the generation of the gnotobiotic ASF + A.muciniphila mouse line 
(ASF+Akk).  
  
  
 
33  
Chapter 4: A. muciniphila induces antigen-specific T 
cell responses during homeostasis 
Many materials in this Chapter have been adapted or reproduced from my 
publication (71): Ansaldo et al. “Akkermansia muciniphila induces intestinal adaptive 
immune responses during homeostasis”, Science, 364, 1179-1184 (2019). Reprinted 
with permission from AAAS. 
Background: 
Despite the large abundance of antigen-experienced T cells in the intestine, very 
few examples of commensal-specific T cell responses have been identified (12). Given 
their roles as orchestrators of immune responses, CD4+ T cells specific for commensal 
antigens are likely to play important roles during homeostasis and disease. Indeed, 
inappropriate T cell responsiveness to the microbiota are considered to be a hallmark of 
IBD (15), and unrestrained T cell responses have been observed in many models of 
colitis in mice (65, 66, 105, 106). Furthermore, commensal-specific T cell responses 
have been hypothesized to help protect against bystander infections (70). Finally, the 
role of such T cell responses during homeostasis still remains poorly understood. In the 
case of SFB, it appears that small intestine Th17 responses help limit the burden of 
SFB in the intestine and prevent dysbiosis (107). Furthermore, Helicobacter-specific 
RORgt+ Treg cells help mediate tolerance against this pathobiont (65). However, outside 
of these two examples and the case of CBir-specific T cells, which remain naïve at 
homeostasis but become activated during infection (68, 69), no other examples of 
commensal-specific T cells have been identified. Thus, identification of novel 
commensal antigens that induce cognate T cell responses during homeostasis would 
help shed light on the breath and role of T cell responses to the microbiota. 
The results obtained in Chapters 2 and 3 show that T cells are required for the 
induction of A. muciniphila-specific IgG1 and IgA. The role for T cells in this response, 
coupled with the presence of antigen-specific, high-affinity antibodies, argues that 
cognate T cell responses to Akkermansia are induced, which would in turn provide T 
cell help for the induction of classical, TD B cell responses. Thus, I hypothesized that A. 
muciniphila-specific T cell responses exist in mice, which are providing T cell help and 
orchestrating effector responses to A. muciniphila.  
Characterization of T cell responses to A. muciniphila may also shed light into 
the mechanisms by which this commensal bacterium exerts effects on host metabolism 
(92, 93) and cancer immunotherapy (100). It is now clear, based on multiple studies, 
that the microbiota influences the outcome of PD-1 cancer immunotherapy in mice and 
humans (56, 100, 108, 109), although the mechanisms are still poorly understood. The 
effects of A. muciniphila on PD-1 cancer immunotherapy in cancer patients correlated 
with IFNg production by peripheral CD4+ T cells upon restimulation with A. muciniphila 
antigens. Interestingly, IFNg also appears to be involved in the influence of Akkermansia 
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on glucose tolerance and metabolism by limiting A. muciniphila colonization, although a 
role for T cells wasn’t explored (93).  
In this chapter, I decided to explore CD4 T cell responses to A. muciniphila 
during homeostasis by generating TCR transgenic mice and peptide:MHCII tetramers 
and characterizing homeostatic T cell responses in gnotobiotic ASF+Akk mice and SPF 
mice.  
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Results: 
I hypothesized that A. muciniphila-specific T cells must exist in intestinal tissues 
of colonized mice at frequencies higher than the precursor frequency. In order to identify 
A. muciniphila-specific T cell receptors (Figure 4.1A), I expanded T cell lines from 
intestinal tissues (mesenteric lymph nodes and Peyer’s patches) of A. muciniphila-
positive SPF mice by repeated stimulation with A. muciniphila-loaded splenocytes. 
Importantly, T cell lines only expanded from A. muciniphila-positive mice (Figure 4.2A); 
and the few T cell lines that expaned from A. muciniphila-negative mice were not 
responding to Akkermansia antigens (Figure 4.2B). From these Akkermansia-specific 
lines I generated T cell hybridomas by fusion with BWZ.36 cells, which enable 
screening for TCR engagement by a colorimetric assay (110, 111). I identified multiple T 
cell hybridomas that responded to A. muciniphila antigens but not E. coli antigens 
(Figure 4.1C). I identified the antigens recognized by two of these hybridomas (124-2 
and 168-H10) by screening an A. muciniphila genomic expression library for clones that 
stimulated each T cell hybridoma (Figure 4.1B and D). The 124-2 hybridoma recognized 
Amuc_RS03735, an outer membrane autotransporter domain-containing protein. 
Further peptide fine-mapping and use of in silico epitope prediction tools identified the 
precise I-Ab binding sequence recognized by 124-2 cells as YIGSGAILS (Figure 4.2C). 
The 168-H10 hybridoma recognized a peptide derived from Amuc_RS07575 (GAPDH).  
To facilitate tracking of the T cell response to A. muciniphila I generated A. 
muciniphila-specific TCR transgenic mice (Amuc124), using the TCRa and TCRb 
chains from the 124-2 T cell hybridoma (Figure 4.1A and D). As expected for an MHCII-
restricted TCR transgenic mouse, T cell development in Amuc124 mice was heavily 
skewed toward CD4+ T cells, and the skewing was even more dramatic in Amuc124 
mice on the Rag1–/– background (Figure 4.3A). Amuc124 T cells proliferated when 
stimulated in vitro with A. muciniphila-loaded splenocytes but not E. coli-loaded 
splenocytes (Figure 4.3B). Importantly, I maintained Amuc124 mice free of A. 
muciniphila colonization for all subsequent experiments.  
Next, I sought to track the T cell response to A. muciniphila by performing low 
frequency adoptive transfers of naïve congenically-marked Amuc124 T cells into ASF 
and ASF+Akk mice (Figure 4.4A). A. muciniphila-specific T cells expanded in ASF+Akk 
mice but were undetectable in ASF mice, indicating that A. muciniphila antigens are 
presented under homeostatic conditions (Figure 4.B and C). Interestingly, Amuc124 T 
cells localized to the Peyer’s patches (PPs) sand mesenteric lymph nodes (mLNs), but 
few cells were found in the small intestine or large intestine lamina propria (SILP or 
LILP) (Figure 4.4B). The majority of transferred T cells expressed PD-1, Bcl6 and 
CXCR5, which are markers for T follicular helper cells (TFH) (Figure 4.4D-G), with a 
small percentage adopting Treg markers (FOXP3). The small amount of T cells 
detectable in the lamina propria were also skewed towards TFH cells, most likely 
indicating that secondary or tertiary lymphoid tissues were not completely excluded from 
these preparations (Figure 4.4G). Surprisingly, I did not detect a significant number of 
transferred T cells that expressed markers for TH1, TH2 or TH17 markers (T-bet, GATA3, 
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or RORgt, respectively) (Figure 4.4G). The fact that I did not observe any T cells in ASF 
mice, which lack A. muciniphila, proves that the responses observed in ASF+Akk mice 
are antigen-specific. However, TCR transgenic mice on a Rag-sufficient background 
exhibit incomplete allelic exclusion and some amount of endogenous rearrangement of 
T cell receptors, particularly in the alpha chain (106, 112). Thus, I crossed the Amuc124 
TCR transgenic mice onto a Rag1–/– background, which prevents rearrangements of the 
endogenous TCR locus and ensures that all T cells express the transgenic T cell 
receptor. Comparing T cell transfers with Amuc124 T cells on a Rag1+/+ or a Rag1–/– 
background yielded similar results (Figure 4.5), which confirms that the response 
observed in ASF+Akk mice is antigen-specific.  
To eliminate the possibility that these surprising results were due to caveats 
associated with T cell transfers, I also examined the endogenous T cell response to A. 
muciniphila. First, I generated I-Ab tetramers loaded with the peptide TLYIGSGAILS 
from the outer membrane protein Amuc_RS03735 (Am3735-1) and confirmed that 
these tetramers bound Amuc124 TCR transgenic T cells (Figure 4.2D). Endogenous, 
tetramer-positive, A. muciniphila-specific T cells were identified in the PPs of ASF+Akk 
but not ASF mice (Figure 4.6A, and B), consistent with the results obtained with 
Amuc124 T cells after adoptive transfer. Moreover, the endogenous A. muciniphila-
specific T cells identified by tetramer staining also expressed TFH cell markers (Figure 
4.6C and D). An independent tetramer with a different Akkermansia epitope from 
Amuc_RS03740 (Am3740-1) predicted in silico yielded very similar results (Figure 4.6B-
D). Finally, I probed all gut-associated lymphoid tissue (LILP, PPs, and SILP) and mLNs 
with both tetramers. A. muciniphila-specific T cells were detected in the PPs but not in 
the lamina propria (Figure 4.6E), which confirmed results obtained with Amuc124 T cell 
transfers. Thus, A. muciniphila induces antigen-specific T cell responses in the intestine 
that manifest primarily as TFH cells in the Peyer’s patches. 
Finally, I returned to SPF mice, where I had observed greater variability in the A. 
muciniphila IgG1 response, and used my newly developed tools to characterize the T 
cell response to A. muciniphila in the context of a conventional microbiota. Similar to my 
findings for the ASF system, transferred Amuc124 T cells expanded and localized to the 
PPs in A. muciniphila-positive mice but were undetectable in A. muciniphila-negative 
mice (Figure 4.7A and B, and Figure 4.8A). The majority of transferred T cells in the 
Peyer’s patches also adopted TFH cell markers (Figure 4.7C and Figure 4.8B) 
Therefore, A. muciniphila also induces a TFH cell response in the context of a complex 
microbiota. However, unlike the ASF+Akk system, greater numbers of transferred T 
cells were detected in the intestinal LP of A. muciniphila-positive mice (Figure 4.7B), 
some of which adopted markers consistent with pro-inflammatory T cell fates (Figure 
4.6D and E, and Figure 4.8C-E). Consistent with the variable A. muciniphila-specific 
IgG1 titers observed in SPF mice (Figure 3.1C), some cohorts of SPF Akk+ mice lacked 
detectable T cell activation and proliferation after transfer, despite the presence of A. 
muciniphila (Data not shown). Thus, T cell responses to A. muciniphila appear to be 
context-dependent, resulting in the induction of other CD4 T effector fates in addition to 
TFH cells in certain conditions. Interestingly, and in contrast to what has been described 
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for segmented filamentous bacteria (SFB) and Helicobacter spp. (59, 64, 65), T cell 
responses to A. muciniphila in SPF mice were mixed between different CD4+ T cell 
fates (Figure 4.8E). 
  
  
 
38  
Discussion: 
Very few commensal antigens have been identified to date that lead to antigen-
specific T cell responses in the gut during homeostasis. SFB and Helicobacter spp. both 
elicit very defined responses. SFB induce RORgt+ TH17 cells both in conventional and 
mono-colonized mice (59), whereas Helicobacter spp. induce RORgt+ FOXP3+ Treg 
cells in the large intestine lamina propria (64, 65). TFH cells comprised a small 
proportion of SFB and Helicobacter-specific T cells, but these were in the context of 
TH17 cell - or Treg cell-dominated responses, respectively (65). TFH cells in the intestine 
have been suggested to differentiate from either TH17 cells or Treg cells (68, 113, 114). 
By contrast, the ASF+Akk system produced commensal-specific T cell responses 
dominated by the induction of TFH cells, with very few Treg, TH1, TH2, or TH17 cells. 
Thus, commensal-specific TFH responses can occur in the absence of a primary CD4+ T 
cell response of a different fate and may differentiate from naïve commensal-specific T 
cells in the mesenteric lymph nodes or Peyer’s patches. Consequently, A. muciniphila 
appears to engage the mucosal immune system in a manner distinct from previously 
described T cell-activating commensal bacteria. This commensal-specific TFH response 
appears in conjunction with robust anti-commensal TD IgG1 and IgA.   
Surprisingly, in the context of a conventional microbiota, and in addition to the 
induction of TFH cells, A. muciniphila can induce CD4+ T cells of other fates that home to 
the lamina propria. Together, these results support the hypothesis that T cell responses 
against commensals can be context-dependent, not just in the setting of acute 
gastrointestinal infection or inflammation (69), but also during homeostasis. Interactions 
with certain microbes may change the localization or function of A. muciniphila, or 
signals provided by other microbes may shape the immune response against this 
commensal bacterium.  
Prior work has established that A. muciniphila mediates effects on host 
metabolism (92, 93) and can influence the efficacy of anti-PD-1-based immunotherapy 
against cancer (100). The mechanisms for these effects remain poorly understood, but 
both appear to be immune-mediated and correlated with type 1 immunity. In particular, 
responses to anti-PD-1-based immunotherapy in humans were correlated with 
interferon gamma production by peripheral T cells incubated with A. muciniphila 
antigens in vitro (100). Interestingly, not all patients generated type 1 responses against 
A. muciniphila. My results provide a potential explanation for this varied response, and 
suggest that differential skewing of A. muciniphila-specific T cell responses in 
individuals due to differences in microbiota composition, or other environmental signals, 
may have profound systemic effects. Defining the mechanisms by which these 
commensal-specific T cell responses can be skewed towards different fates is an 
important goal with clear clinical implications.    
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Methods: 
Animals: 
Mice were housed under specific-pathogen-free (SPF) or gnotobiotic conditions 
at UC Berkeley. For SPF experiments, adult (8-16 weeks of age, male and female) 
C57BL/6J mice were used as wild-type mice. All experiments were performed in 
accordance with the Animal Care and Use Committee guidelines at the University of 
California Berkeley. For gnotobiotic experiments, gnotobiotic C57BL/6NTac mice 
colonized with altered Schaedler’s flora were obtained from Taconic Biosciences and 
imported into the gnotobiotic facility at the University of California Berkeley. ASF and 
ASF+Akk mouse colonies were maintained in separate flexible film isolators (Class 
Biologically Clean). ASF+Akk mice were generated from C57BL/6NTac ASF mice by 
two oral gavages of 109 cfu of Akkermansia muciniphila (colony isolate) 2 days apart. 
Colonization with A. muciniphila was tested by 16S A. muciniphila fecal qPCR and 
absence of contaminants was routinely tested by bacterial plating and fecal 16S rDNA 
sequencing. For experiments including ASF+Akk mice, I analyzed progeny (or progeny 
of progeny) of A. muciniphila-gavaged mice. I used littermate mice for SPF Akk-positive 
T cell transfers in Figures 4.7 and 4.8, except for one of the repeats (Figure 4.8E 
Experiment 2), which consisted of two groups of littermate mice.  
 A. muciniphila-positive and A. muciniphila-negative C57BL/6J mouse 
colonies were kept and bred under SPF conditions. A. muciniphila-positive mice were 
already present in the mouse colony at the University of California Berkeley. For these 
experiments, I  determined that a 3-week course of tetracycline hydrochloride in the 
drinking water (3 g/L tetracycline hydrochloride, 1% sucrose, pH=7, changed every 3 
days) was sufficient to clear mice of A. muciniphila. I  analyzed progeny (or progeny of 
progeny) of tetracycline-treated mice for SPF experiments in this chapter.  
 For adoptive T cell transfers into ASF and ASF+Akk mice, animals were 
removed from gnotobiotic isolators and transferred into sterilized cages within a 
biosafety cabinet. Mice were anesthetized by the isoflurane drop jar method and T cells 
were transferred by retro-orbital injection. Mice were then housed for 12 days in 
sterilized cages on a ventilated rack within the barrier facility at the University of 
California, Berkeley, without further manipulation. Absence of contaminating microbes 
was tested by plating on different media at the time of euthanasia. 
Isolation and culture of A. muciniphila: See previous chapter 
Fecal A. muciniphila 16S qPCR: See previous chapter 
Cell and tissue culture conditions: 
 T cell lines were generated from mesenteric lymph nodes and Peyer’s 
patches of SPF mice 2-3 weeks after oral gavage of 109 cfu (A. muciniphila-colonized). 
CD4 T cells were isolated using magnetic separation with CD4 beads (L3T4, Miltenyi 
Biotec) and incubated with irradiated splenocytes that had been loaded with A. 
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muciniphila (MOI = 50), which was prepared from a 36-48-h culture by resuspending at 
OD=1 and heat-killing at 95ºC for 30 min. T cells were incubated in RPMI-10: RPMI + 
10% (v/v) fetal bovine serum (FBS) supplemented with L-glutamine, penicillin-
streptomycin, sodium pyruvate and HEPES (pH=7.2) (Invitrogen). Recombinant IL-2 (10 
U/mL) was added to the second and subsequent rounds of stimulation. T cell lines were 
stimulated every 7 days, with removal of dead cells on Ficoll separation media (MP 
Biomedicals).  
 T cell hybridomas were generated by fusion of the myeloma cell line 
BWZ.36 with the generated T cell lines as previously described (110, 115). T cell 
hybridomas were cultured in RPMI-10 and stimulated with splenocytes loaded with the 
indicated antigens. Anti-CD3 (145-2C11) and anti-CD28 (37.51) were used at 2 µg/mL 
as a positive control. Overnight E. coli (DH5a) or 36-48-h A. muciniphila cultures were 
harvested, resuspended at OD 1 in PBS and heat-killed at 95ºC for 30 min before being 
added to splenocytes at the indicated ratios (MOI). After overnight incubation, b-
galactosidase activity (the reporter of TCR stimulation in BWZ.36 cells) was measured 
in a bulk assay or on a single cell basis as previously described (110). For bulk assays, 
cells on a 96-well plate were washed with PBS and resuspended in CPRG buffer 
(0.125% (v/v) NP-40, 9mM MgCl2, 0.15mM chlorophenol red-β-D-galactopyranoside 
(CPRG) in PBS) and incubated at 37C for 4 h. Absorbance at 595nm was measured 
with 635nm as a reference. Single cell b-galactosidase activity was measured in the 
screen described in figure S4C. For single cell assays, cells were washed in PBS, fixed 
in 2% (v/v) formaldehyde 0.2% (v/v) glutaraldehyde solution, washed in PBS and 
overlaid with X-gal staining solution (2 mM MgCl2, 5 mM K4Fe(CN)6, 5 mM K3Fe(CN)6 
and 1 mg/mL X-gal (5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside) in PBS). After 
an overnight incubation at 37ºC, blue cells were quantified using light microscopy.   
 For stimulation of primary Amuc124 TCR transgenic T cells, CD4 T cells 
were isolated by magnetic separation with CD4 beads (L3T4, Miltenyi Biotec) and 
labeled with carboxyfluorescein succinidyl ester (CFSE) (Invitrogen) according to 
manufacturer’s instructions. CFSE-labeled T cells were incubated with antigen-loaded 
splenocytes in the presence of 20 U/mL recombinant IL-2. Three days later samples 
were stained for flow cytometry and proliferation was measured on a BD LSR Fortessa 
or LSR Fortessa X-20. 
Identification of hybridoma-stimulating peptides: 
T cell hybridomas 124-2 and 168-H10-1 were used to screen a genomic 
expression library (from A. muciniphila) as previously described (111). Briefly, a partial 
digest of A. muciniphila genomic DNA using Sau3A1 was cloned into the IPTG-inducible 
expression vector pGEX-4T3 and electroporated into DH10B T1R E. coli ElectroMax 
electrocompetent cells (ThermoFisher) to generate a library. Pools of 30 clones were 
screened for their ability to stimulate individual T cell hybridomas by the single cell b-
galactosidase assay as described above. Individual stimulatory clones were isolated 
from stimulatory pools and their inserts were sequenced and mapped to the published 
A. muciniphila genome sequence (91). The stimulatory region was narrowed down by 
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cloning smaller fragments into the pGEX-4T3 vector. Candidate epitopes were identified 
using both in-house and online peptide-MHCII binding prediction tools (116, 117). 
Candidate peptides were ordered from Genscript and tested for their ability to stimulate 
the 124-2 T cell hybridoma.  
Cell isolation: 
 Cells from mesenteric lymph nodes, Peyer’s patches (including cecal 
patch), spleen and thymus were isolated by mechanical dissociation on a 70-µm filter. 
Cells from small intestine lamina propria (after removal of Peyer’s patches) and large 
intestine lamina propria (cecum and colon, after removal of cecal patch) were cut 
longitudinally after removing excess adipose tissue, washed in PBS and incubated at 
37ºC for 20 min with stirring in Hank’s balanced salt solution (HBSS) with 1 mM DTT, 
10% (v/v) FBS, penicillin–streptomycin and HEPES. Intestines were then incubated at 
37ºC for 25 min with stirring in HBSS with 1.3 mM EDTA, penicillin–streptomycin and 
HEPES, with further dissociation of epithelial cells in 10 mL PBS by shaking. Tissues 
were digested in RPMI with collagenase VIII (1 mg/mL, Sigma), DNaseI (5 µg/mL, 
Sigma), penicillin–streptomycin and HEPES for 45 min, and lymphocytes were collected 
at the interface of a 44%/67% Percoll gradient (GE Healthcare).  
Generation of Amuc124 TCR transgenic mice: 
124-2 T cell hybridoma paired TCRa and TCRb sequence usage was identified 
by nested RT-PCR as previously described (118). Rearranged VDJ regions were 
amplified from genomic DNA from the 124-2 hybridoma using the following primers: 
124F: 5ʹ-GATCTCAGTCCTCAGTGAAGAGG-3ʹ, 124R: 5ʹ-
CCCTGTACATTGCAGGAATATCC-3ʹ 
(plus restriction enzyme target sequences) and cloned into the pTa and pTb 
cassettes (119). TCR transgenic mice were generated at the Cancer Research 
Laboratory Gene targeting facility at the University of California Berkeley by 
microinjection of linearized plasmids into C57BL/6J one-cell embryos. Positive pups 
were genotyped by PCR and maintained free of A. muciniphila colonization.  
T cell adoptive transfers: 
 Peripheral lymph nodes and spleen of A. muciniphila-negative Amuc124 
TCR transgenic Thy1.1 mice were dissociated mechanically on a 70-µm filter. Naïve 
CD4 T cells (CD3+ CD4+ CD62L+ CD44lo) were sorted on a BD FACSAria Fusion cell 
sorter and 10,000 cells were transferred by retro-orbital injection into C57BL/6 recipient 
mice (Thy1.2). Recipient mice were analyzed 12 days post adoptive T cell transfer.  
Flow cytometry and sorting: 
 Cells were isolated as described above and stained in a 96-well U-bottom 
plate. Dead cells were excluded with a fixable Near-IR or Aqua live/dead dye (Life 
technologies) in PBS. Surface staining was performed in PBS with 2% FBS (v/v), 1 mM 
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EDTA and 0.1% NaN3 for 30 min at 4ºC, or for 1 h at room temperature (RT) when 
staining for CXCR5 (no NaN3). Staining with tetramers was performed for 30’ at 37C in 
the presence of 50 nM Dasatinib (Sigma), followed by an additional 30’ at RT. Anti-
CXCR5 antibodies were included in this tetramer staining step, and the rest of surface 
staining was performed in a subsequent step for 30’ at 4˚C. Intracellular transcription 
factor staining (eBioscience buffer set, ThermoFisher) was performed by fixation for 1 h 
at RT and staining for 40 min at RT. Samples were analyzed on a BD LSR Fortessa or 
a BD LSR Fortessa X-20. The list of antibodies used can be found in Table S1.  
Computational prediction and validation of the Am3740-1 epitope: 
Utilizing BOTA, a previously described computational algorithm for predicting 
microbial epitopes from genomic data (120), the top 10 epitopes most likely to be 
immune-dominant from the strain Akkermansia muciniphila ATCC BAA-835 were 
predicted. Next, Xavier, R. and colleagues analyzed which of these epitopes were 
specific to A. muciniphila by using BLAST on all known public databases with published 
bacterial genomes. Three of the ten epitopes were predicted to be from proteins 
restricted to A. muciniphila genomes only, and these 3 peptides were synthesized for 
further validation of MHCII binding and activity. Peptides from the three predicted 
epitopes were re-suspended in DMSO and screened for production of cytokines by 
pulsing murine splenocytes with each peptide for 18 h at 37°C as described previously 
(120). Cytokine production was measured by cytometric bead array (Flex Set; BD 
Biosciences) for IFN-γ (cat no. 558296), IL-17A (cat no. 560283), and IL-10 (cat no. 
558300), and the LIFESSNALGLGR peptide was selected for tetramer production. 
Generation of I-Ab tetramers: 
The Am3735-1 and Am3740-1 I-Ab tetramers were constructed by previously 
described methods (121). The peptide sequences used to generate tetramers were the 
following: TLYIGSGAILS (Am3735-1) or LIFESSNALGLGR (Am3740-1), consisting of 
the 9-mer MHCII-binding cores of the epitope plus 2 additional N-terminal residues, and 
also 2 additional C-terminal residues for Am3740-1. In brief, these peptide sequences 
were encoded as covalent fusions to soluble heterodimeric I-Ab molecules stably 
expressed in Drosophila S2 cells. Purified biotinylated peptide:MHCII complexes were 
then tetramerized with PE or APC fluorochrome-conjugated streptavidin (Prozyme). 
Quantification and statistical analysis: 
 Statistical tests were performed as indicated on the figure legends with 
Prism 8 software (Graphpad Prism). 
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Table S1: Antibody list 
Target Fluorophores Clone Dilution Concentration Company 
CD3 BV421, PerCP-Cy5.5 145-2C11 1/200 1 µg/mL BD Horizon 
CD4 BV785, APC GK1.5 1/200 1 µg/mL Biolegend 
CD44 BV711, FITC IM7 1/400 0.5 µg/mL Biolegend 
Thy1.1 BUV395, BV650 OX7 1/400 0.5 µg/mL BD optibuild 
PD-1 PE-Cy7 J43 1/200 1 µg/mL invitrogen 
FOXP3 Alexa Fluor (AF) 488  FJK-16s 1/250 2 µg/mL eBioscience 
CXCR5 AF 647, BV650 L138D7 1/100 2 µg/mL Biolegend 
RORgt PE AFKJS-9 1/100 2 µg/mL invitrogen 
T-bet PE-Cy7 4B10 1/200 0.5 µg/mL Biolegend 
GATA3 AF 647 L50-823 1/20 NA BD Pharmigen 
Bcl6 PE K112-91 1/50 NA BD Horizon 
CD62L  PE MEL-14 1/200 1 µg/mL Tonbo 
CD8 eFluor 450 53-6.7 1/400 0.5 µg/mL eBioscience 
Fc Block NA 2.4G2 1/200 2.5 µg/mL UCSF  
TCRb APC H57-597 1/100 2 µg/mL TONBO 
B220 FITC, PercP-Cy5.5 RA2-6B2 1/200 1 µg/mL Biolegend 
CD11c FITC N418 1/200 2.5 µg/mL eBioscience 
CD11b FITC M1/70 1/200 2.5 µg/mL Biolegend 
Near-Ir L/D NA NA 1/1000 NA Invitrogen 
Aqua L/D NA NA 1/1000 NA Invitrogen 
IgG1 biotinylated A85-1 1/200 2.5 µg/mL BD Pharmigen 
IgG2b biotinylated R12-3 1/200 2.5 µg/mL BD Pharmigen 
IgG2a biotinylated 5.7 1/200 2.5 µg/mL BD Pharmigen 
IgG3 biotinylated R40-82  1/200 2.5 µg/mL BD Pharmigen 
IgA biotinylated Polyclonal (1040-08)  1/200 2.5 µg/mL 
Southern 
Biotech 
SA-PE-Cy7 PE-Cy7 NA 1/200 1 µg/mL eBioscience 
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Figures: 
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Figure 4.1. Generation of A. muciniphila-specific hybridomas, TCR transgenic 
mice, and I-Ab tetramers 
(A) Diagram summarizing the generation of A. muciniphila-specific T cell lines from A. 
muciniphila-colonized mouse intestinal tissues, generation of T cell hybridomas and 
TCR transgenic mice.  
(B) Stimulation of T cell hybridomas with splenocytes loaded with the indicated 
antigens. Data are representative of >3 independent experiments. 
(C) Diagram summarizing the identification of A. muciniphila antigens recognized by 
individual T cell hybridomas via screening of an expression library of A. muciniphila 
genomic DNA. 
(D) Summary table of TCR gene usage, CDR3 sequence and antigen specificity for the 
indicated A. muciniphila-specific T cell hybridomas. 
(E) Stimulation of A. muciniphila-specific T cell hybridoma 124-2 with an identified 
peptide from the protein RS03735. A serial dilution of peptide was used to test for 
specificity.  
(F) Staining of Amuc124 Rag1–/– TCR transgenic T cells with Am3735-1 tetramer. Data 
are representative of two independent experiments. 
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Figure 4.2. Generation of A. muciniphila-specific I-Ab tetramers and validation of T 
cell lines 
(A) Cell numbers for 6 of the T cell lines: 2 T cell lines derived from intestinal tissues 
(mLN and PP) of A. muciniphila-colonized mice 14-21 days post oral gavage (Akk-
colonized), and 4 T cell lines derived from intestinal tissues of A. muciniphila-negative 
mice (Akk-negative). All T cell lines were diluted ½ after seven days and Akk-colonized 
T cell lines were diluted 1/5 on day 14. All T cell lines were stimulated with A. 
muciniphila-loaded irradiated splenocytes on day 0. At the end of each week live cells 
were collected on a Ficoll gradient and stimulated with A. muciniphila-loaded irradiated 
splenocytes for another week. 
(B) Proliferation ratios of seven T cell lines. T cell lines were labeled with CFSE and 
incubated for three days with irradiated splenocytes loaded with different antigens or 
nothing (unstimulated). T cells that proliferate dilute their CFSE and thus have lower 
CFSE gMFI. Thus, the proliferation ratio for each antigen was calculated as the inverse 
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of the gMFI ratio over unstimulated. The hybridoma 124 (and Amuc124 TCR transgenic 
mice) were derived from Akk-colonized line 4. 
(C) Stimulation of A. muciniphila-specific T cell hybridoma 124-2 with an identified 
peptide from the protein RS03735. A serial dilution of peptide was used to test for 
specificity.  
(D) Staining of Amuc124 Rag1–/– TCR transgenic T cells with Am3735-1 tetramer. Data 
are representative of two independent experiments. 
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Figure 4.3 Characterization of Amuc124 TCR Transgenic mice 
(A) Representative flow cytometric analysis of spleen and thymus for the indicated 
mice. n=3 mice per group.  
(B) Amuc124 Rag1+/+ TCR transgenic T cells were labeled with the proliferation dye 
CFSE and stimulated with the indicated antigens for 3 days. Proliferation was measured 
by flow cytometry. Data are representative of two independent experiments. Gates on 
flow cytometry plots show mean±SEM 
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Figure 4.4. A. muciniphila induces antigen-specific T follicular helper cell 
responses during homeostasis 
(A) Experimental design of Amuc124 TCR transgenic T cell adoptive transfers. Ten 
thousand naïve (CD44lo CD62L+ CD3+ CD4+) Amuc124 TCR Transgenic T cells 
expressing the congenic marker Thy1.1 were transferred for all adoptive transfers. 
(B) Frequencies of transferred T cells in intestinal tissues of ASF and ASF+Akk mice. 
n=5 mice per group, data are representative of six independent experiments. 
(C) Representative flow cytometric analysis depicting transferred T cells (Thy1.1+) as 
percentage of all CD4+ T cells in the Peyer’s patches of ASF and ASF+Akk mice 12 
days after low-frequency adoptive transfer of Amuc124 TCR transgenic T cells. 
Quantified in (B).  
(D and E) Representative flow cytometric analysis of expression of T follicular helper 
markers (PD-1, Bcl6, and CXCR5) by endogenous and transferred T cells in the Peyer’s 
patches of ASF+Akk mice. 
(F) Total transferred T cell percentages expressing TH1 (T-bet+ FOXP3–), TH2 (GATA3+ 
FOXP3–), TH17 (RORgt+ FOXP3–), Treg (FOXP3+) or TFH (Bcl6+ PD-1+) markers in gut-
associated lymphoid tissue (SILP, LILP and PP) and mesenteric lymph nodes (mLN) in 
ASF+Akk mice 12 days post Amuc124 TCR transgenic adoptive transfer. Numbers for 
each CD4 T cell fate were analyzed separately for each tissue and then combined 
together for this analysis. n=4 mice, data are representative of six independent 
experiments.  
(G) Expression of TH1 (T-bet+ FOXP3–), TH2 (GATA3+ FOXP3–), TH17 (RORgt+ FOXP3–
), Treg (FOXP3+) or TFH (Bcl6+ PD-1+) markers by transferred T cells in intestinal tissues 
of ASF+Akk mice. Data are representative of six independent experiments. 
Each symbol represents a mouse, error bars represent mean ± SD. Gates on flow 
cytometry plots show mean±SEM. p-values were calculated with unpaired Student’s t-
tests (B). 
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Figure 4.5. Amuc124 TCR transgenic Rag1+/+ and Rag1–/– cells expand similarly in 
ASF+Akk mice 
(A and C) Numbers of transferred T cells in intestinal tissues of ASF and ASF+Akk mice 
post adoptive transfer of Amuc124 TCR transgenic Rag1+/+ cells (A) or Amuc124 TCR 
transgenic Rag1–/– cells (C). n=4 (A) or n=5 (C) mice per group. Data are representative 
of three independent experiments.    
(B and D) Expression of TH1 (T-bet+ FOXP3–), TH2 (GATA3+ FOXP3–), TH17 (RORgt+ 
FOXP3–), Treg (FOXP3+) or TFH (Bcl6+ PD-1+) markers by transferred T cells in the 
Peyer’s patches of ASF+Akk mice post adoptive transfer of Amuc124 TCR transgenic 
Rag1+/+ cells (B) or Amuc124 TCR transgenic Rag1–/– cells (D). n=4 (B) or n=5 (D) mice 
per group. Data are representative of three independent experiments. 
Each symbol represents a mouse, error bars represent mean ± SD. p-values were 
calculated with unpaired Student’s t-tests.  
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Figure 4.6. Endogenous A. muciniphila-specific T cells localize to the Peyer’s 
patches and adopt TFH markers.  
(A) Representative Am3735-1 tetramer flow cytometric analysis of Peyer’s patches from 
ASF and ASF+Akk mice.  
(B) Frequencies of Am3735-1 or Am3740-1 tetramer+ endogenous T cells in ASF and 
ASF+Akk mice as a percentage of total CD4+ T cells. n=4 ASF, n=5-7 ASF+Akk mice. 
Data are representative of three (Am3740-1) or six (Am3735-1) independent 
experiments. 
(C) Frequencies of Am3735-1 or Am3740-1 tetramer+ cells expressing TFH markers (PD-
1 and CXCR5, as shown in (D)) in the PPs of ASF+Akk mice. n=5-7 mice, data are 
representative of three (Am3740-1) or six (Am3735-1) independent experiments. 
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(D) Representative flow cytometric analysis of expression of TFH markers (PD-1 and 
CXCR5) by endogenous Am3735-1 or Am3740-1 tetramer+ cells. 
(E) Numbers of Am3735-1 and Am3740-1 tetramer+ cells in all intestinal tissues in ASF 
and ASF+Akk mice. n=4 ASF, n=5 ASF+Akk mice. Data are representative of two 
(Am3740-1) or three (Am3740-1) independent experiments.  
Each symbol represents a mouse, error bars represent mean ± SD. Gates on flow 
cytometry plots show mean±SEM. p-values were calculated with unpaired Student’s t-
tests (E), or a Mann–Whitney test (B). 
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Figure 4.7. A. muciniphila-specific T cells adopt other fates in the context of a 
complex microbiota 
(A) Representative flow cytometric analysis depicting transferred Amuc124 T cells 
(Thy1.1+) as percentage of all CD4+ T cells in the Peyer’s patches of SPF Akk– and SPF 
Akk+ mice.  
(B) Frequencies of transferred T cells as percentage of all CD4+ T cells in intestinal 
tissues of conventional specific pathogen-free (SPF) A. muciniphila– (n=4) and SPF A. 
muciniphila + (n=5) mice. Data are representative of three independent experiments. 
(C and D) Expression of TH1 (T-bet+ FOXP3–), TH2 (GATA3+ FOXP3–), TH17 (RORgt+ 
FOXP3–), Treg (FOXP3+) or TFH (Bcl6+ PD-1+) markers by transferred T cells in the 
Peyer’s patches (C) or small intestine lamina propria (D) of SPF A. muciniphila + mice. 
n=5 mice, data are representative of three independent experiments. 
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(E) Representative flow cytometric analysis of expression of TH1 and TH17 markers by 
endogenous total CD4+ T cells and A. muciniphila-specific (transferred) T cells in the 
SILP of SPF A. muciniphila + mice.  
Each symbol represents a mouse, error bars represent mean ± SD. Gates on flow 
cytometry plots show mean±SEM. p-values were calculated with unpaired Student’s t-
tests (B).  
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Figure 4.8. A. muciniphila-specific T cells adopt TFH but also TH1 and TH17 
markers in SPF Akk+ mice   
(A) Quantification of A. muciniphila colonization by fecal 16S qPCR for SPF Akk– (n=4) 
and SPF Akk+ mice (n=5). Applies to experiments in Fig. 4 and this figure. Data are 
representative of three independent experiments.  
(B) Representative plot of TFH marker expression (Bcl6 and PD-1) by transferred T cells 
in the Peyer’s patches of SPF Akk+ mice. 
(C and D) Expression of TH1 (T-bet+ FOXP3–), TH2 (GATA3+ FOXP3–), TH17 (RORgt+ 
FOXP3–), Treg (FOXP3+) or TFH (Bcl6+ PD-1+) markers by transferred T cells in the LILP 
(C) or mLN (D) of SPF Akk+ mice. Data are representative of three independent 
experiments. 
(E) Total transferred T cell percentages expressing TH1 (T-bet+ FOXP3–), TH2 (GATA3+ 
FOXP3–), TH17 (RORgt+ FOXP3–), Treg (FOXP3+) or TFH (Bcl6+ PD-1+) markers in gut-
associated lymphoid tissue (SILP, LILP and PP) and mesenteric lymph nodes (mLN) of 
two independent experiments in SPF Akk– and SPF Akk+ mice. Numbers for each CD4 
T cell fate were analyzed separately for each tissue and then combined for these plots. 
Each symbol represents a mouse, error bars represent mean ± SD. Gates on flow 
cytometry plots show mean±SEM. p-values were calculated with a Mann–Whitney test 
(A). 
  
0
20
40
60
80
100
Tr
an
sfe
rre
d T
 ce
lls
 (%
)
TH1 TH17TH2 Treg TFH
0
20
40
60
80
100
Tr
an
sfe
rre
d T
 ce
lls
 (%
)
TH1 TH17TH2 Treg TFH
LILP
mLN
0
20
40
60
80
100
Tr
an
sfe
rre
d T
 ce
lls
 (%
)
TH1 TH17TH2 Treg TFH
Total transferred T cells in 
GALT + mLN, SPF
Experiment 2
0
20
40
60
80
100
Tr
an
sfe
rre
d T
 ce
lls
 (%
)
TH1 TH17TH2 Treg TFH
Total transferred T cells in 
GALT + mLN, SPF
Experiment 1
C
D E
SPF
 B6
 Akk
–
SPF
 B6
 Akk
+
103
104
105
106
107
108
109
1010
A.
 m
uc
ini
ph
ila 
ge
no
m
e 
eq
uiv
ale
nts
 / g
 fe
ce
s
LoD
A p =0.0159
PP, Transferred T cells
50.3±4.5
Bcl6
PD
-1
B
  
 
57  
Chapter 5: Description of a novel mouse line that 
induces ectopic responses to the microbiota 
Part of the work presented in this chapter was performed with the help of Shaina 
Carroll.  
Background: 
Conditions of intestinal infection or inflammation are known to induce 
proinflammatory T cell fates against commensal antigens that are ignored during 
homeostasis (69), and immune dysregulation caused by lack of the anti-inflammatory 
cytokine IL-10 leads to proinflammatory responses to Helicobacter spp., which drive 
colitis in  IL-10 deficient mice (65, 66, 122). In addition, T cell responses to the 
microbiota could provide bystander protection against pathogen infection, but can also 
pose a pathogenic risk if they become dysregulated (70).  
Prior to this work, there were no examples of homeostatic T cell responses to 
intestinal commensal antigens that changed based on contextual signals in wild-type 
mice. The varying T cell fates I observed to A. muciniphila in SPF mice (Chapter 4) 
suggest that responses to commensal bacteria can be context-dependent, which 
doesn’t appear to be the case for SFB or Helicobacter spp. (59, 65). Only CBir1 induces 
different kinds of responses in different inflammatory contexts, but this occurs in the 
absence of a steady state response, since this antigen does not induce T cell responses 
during homeostasis (68, 69). Thus, I became very interested in understanding what 
signals can change the response to A. muciniphila and lead to pro-inflammatory T cell 
fates (Th1, Th17). Elucidating these signals would not only help understand overall 
host-microbiota interactions during inflammation and the subsequent return to 
homeostasis, but may also shed light into some of the specific mechanisms that A. 
muciniphila engages to mediate its protection in metabolic disease and PD-1 cancer 
immunotherapy (92, 93, 100). Of particular interest is the fact that Type-I CD4+ T cell 
responses to A. muciniphila correlated with improved responsiveness to PD-1 therapy.   
One could envision attempting to modulate the response to A. muciniphila in 
mice modeling what would occur in humans: through intestinal infection and 
inflammation. Preliminary results suggested that the response to A. muciniphila may 
change under DSS-induced colitis (Data not shown), but I haven’t performed those 
experiments enough times and will not discuss them here. During my studies exploring 
T cell responses to A. muciniphila in SPF mice, I encountered a very striking phenotype 
in a specific mouse line, which quickly became the focus of my work, and I will describe 
my current findings in this chapter.  
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Results: 
During my experiments in SPF mice in Chapter 4, I encountered a very 
surprising result in a specific mouse line: C57BL/6 (B6) and SJL are two inbred mouse 
strains used in research. B6 mice are widely used in the field of immunology, and many 
genetic tools, mouse knockouts, reporters of gene expression etc exist in this genetic 
background. The SJL mouse strain carries a distinct allele of the gene CD45, among 
many other genes. The polymorphism in CD45 between the two alleles does not impact 
function, but creates different epitopes that are recognized by two different monoclonal 
antibodies (123). The CD45 allele of B6 mice is named CD45.2 (or Ly5.2), and the 
CD45 allele of SJL mice, is named CD45.1 (or Ly5.1). The CD45.1 allele from SJL mice 
has been backcrossed onto the B6 background, thus generating C57BL/6.SJL (or 
B6.SJL) mice. B6.SJL mice are isogenic to B6 mice except for carrying the CD45 locus 
from SJL mice (or “congenic”), although additional polymorphisms can occur (124, 125). 
B6.SJL mice are widely used as congenics in models of adoptive cell transfers, 
transplantation, bone marrow chimeras etc as a method to track cell origin via CD45.1 
and CD45.2. A major assumption in these transfer experiments is that the donor (B6 or 
B6.SJL) and recipient cells (B6.SJL or B6, respectively) share the same genetic 
background.  
With the goal of characterizing the T cell response to A. muciniphila in 
conventional mice, I performed Amuc124 TCR transgenic adoptive transfers into SPF 
C57BL/6 mice (Figure 4.7 and 4.8) and also B6.SJL mice, since both of these strains 
are considered to be wild-type and isogenic except for the CD45 locus. However, 
performing low frequency Amuc124 T cell adoptive transfers into B6.SJL mice revealed 
very exuberant T cell responses compared to B6 controls. A. muciniphila-specific T cells 
expanded dramatically in B6.SJL mice, homed preferentially to the SILP and adopted 
Th17 markers, but also homed to the PP and LILP (Figure 5.1A and B). For the purpose 
of this work, I renamed B6.SJL mice housed in the Barton lab at UC Berkeley from early 
2010s until 2019 as B6.SJL*. Amuc124 T cells reached extremely high frequencies (% 
of CD4+ T cells) in B6.SJL* mice, particularly in the small intestine (Figure 5.1A and B). 
These frequencies are orders of magnitude larger than the frequencies observed in the 
ASF+Akk and B6 SPF mice, or the frequencies observed for SFB or Helicobacter-
specific T cells with similar experimental design (59, 65), evidencing the large degree of 
expansion of Amuc124 T cells in B6.SJL* mice.  
Two non-mutually exclusive hypothesis exist to explain these surprising results: 
First, differences in microbiota composition, such as the presence of an ongoing 
infection in the B6.SJL* mice, could account for this exuberant response. Second, the 
phenotype has a genetic basis: B6.SJL* mice may harbor a polymorphism or mutation 
in an immunoregulatory gene that leads to this response. Transferred T cells have a B6 
genetic background and don’t present the same phenotype in other strains of mice. 
Consequently, if genetic, this phenotype would occur in a Amuc124 T cell-extrinsic 
manner.  
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Initially, I favored the first hypothesis. A. muciniphila has been shown to bloom 
in mucosal wound beds in the intestine in a manner dependent on the induction of 
hypoxia and MUC3 (98). I hypothesize that A. muciniphila may become a major 
mucosal antigen during events that lead to intestinal infection, wounding or 
inflammation. This would be mediated through an increase in A. muciniphila 
colonization on the inflamed/wounded/infected epithelium due to its production of 
hypoxic conditions and upregulation of Muc3 mucin.  Subsequent sampling in situ by 
immune cells would lead to potent induction of T cell responses to this epithelium-
associated bacterium in the context of inflammation.   
If the phenotype that I observed is due to microbiota composition, this would 
predict that this phenotype would be transferrable to B6 mice. To test this, I performed 
cohousing experiments in which I cohoused A. muciniphila-positive B6 and B6.SJL* 
mice from the moment of weaning until the age of 10-12 weeks, and then performed 
Amuc124 T cell adoptive transfers. These experiments, however, failed to transfer the 
phenotype to B6 mice, while B6.SJL* mice that were cohoused with B6 mice maintained 
the same exuberant T cell responses post transfer (Figure 5.2C). The percentage of 
transferred T cells expressing Th17, Th1 and TFH markers was similar between the 
groups, but B6.SJL* mice had higher percentage of Th17 in the SILP and a substantial 
increase in the magnitude of the response (Figure 5.2C and D).  
During the course of experiments, I realized that B6.SJL* mice presented 
increased amounts of endogenous polyclonal T-bet+ FOXP3– CD4+ T cells (which are 
markers of Th1 cells) in intestinal but also systemic secondary lymphoid organs (Figure 
5.3A and B). Importantly, this phenotype was observed even when adoptive transfers of 
Amuc124 T cells were not performed (Figure 5.2B). Analysis of previous experiments 
involving Amuc124 T cell adoptive transfers into B6 and B6.SJL* mice revealed the 
same increase in polyclonal Th1 cells when looking at the non-TCR transgenic 
endogenous population in the spleen and mLNs (Figure 5.2C). However, this phenotype 
appears to be incompletely penetrant (Figure 5.2C), despite the fact that all these mice 
were cohoused littermates. This incomplete penetrance is also true for the Amuc124 T 
cell adoptive transfers (Figure 5.1B), and correlates with the exuberant Amuc124 T cell 
activation (Data not shown). While I lack the numbers and experiments to support this 
claim, it appears that this phenotype is more prevalent as the mice age, which is also a 
hallmark of other mouse models of colitis (126). Furthermore, I have observed that 
B6.SJL* mice present with frequent rectal prolapse and enlarged mesenteric lymph 
nodes, both signs of intestinal inflammation and disease, although I haven’t quantified 
this rigorously yet (Data not shown).  
To further test the transferability of this phenotype, I performed fecal microbiota 
transplants into germ-free mice. I collected intestinal contents from A. muciniphila-
positive B6 or B6.SJL* mice and immediately performed oral gavages into adult germ-
free mice that were subsequently housed under SPF conditions. I selected B6.SJL* 
mice with signs of intestinal inflammation for this fecal transplant. After 30 days, but also 
after 60 days in a second cohort, I performed Amuc124 T cell adoptive transfers and 
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also analyzed the endogenous CD4+ T cell compartment (Figure 5.3A). Ex-germ-free 
(ExGF) mice that received B6.SJL* microbiota induced similar responses to A. 
muciniphila upon T cell adoptive transfer compared to mice that received B6 microbiota 
(Figure 5.3B). The expansion of transferred T cells was similar to the results observed 
in SPF A. muciniphila-positive B6 mice (Figure 4.7). In addition, the endogenous CD4+ 
T cell compartment between these two groups was almost identical, with no signs of an 
increase in Th1 cells in the mice that received B6.SJL* microbiota (Figure 5.3C). In 
conclusion, these data show that neither of the two phenotypes observed in B6.SJL* 
mice, the exuberant expansion of Amuc124 transferred T cells or the aberrant 
endogenous Th1 responses, can be readily transferred by microbiota transplantation. 
These results argue against the hypothesis that the phenotype observed in 
B6.SJL* mice is due to a distinct microbiota, and point to a for a genetic underpinning 
instead. To see if this was a general feature of all B6.SJL mice, I obtained new B6.SJL 
mice from Jackson laboratories, and preliminary observations suggest that “fresh” 
B6.SJL/J mice don’t present the same phenotypes (Data not shown). Thus, I predict 
that the B6.SJL* mouse line has acquired a de novo spontaneous mutation that has 
been fixed in the mouse colony in the Barton lab at UC Berkeley due to repeated sibling 
inbreeding. Inbreeding is the standard practice to maintain mouse lines and keep track 
of genotypes, such as the absence of a particular gene that has been knocked out or, in 
this case, the presence of the congenic marker CD45.1. However, inbreeding carries 
the risk of acquiring new polymorphisms compared to the C57BL/6 strain, which can 
reach fixation in the colony after many generations.  
Aberrant Th1 responses, intestinal inflammation, enlarged mLNs and rectal 
prolapse are all the major phenotypes present in the IL-10-deficient mouse model of 
colitis (66, 105, 127), which depends on the presence of Helicobacter spp. to trigger 
disease. B6.SJL* mice exhibit all these same phenotypes, and Helicobacter spp. are 
present in the mouse colony at UC Berkeley (Data not shown). Thus, I decided to test 
the IL-10 pathway in B6.SJL* mice before embarking on more complicated genetic 
analyses, such as crosses and genome sequencing approaches. I generated Bone-
marrow derived macrophages (BMMs) from B6 and B6.SJL* mice, and tested their 
ability to respond to and produce interleukin 10 (IL-10). B6.SJL* BMMs responded 
similarly to B6 BMMs as measured by STAT3 phosphorylation (Y705) upon stimulation 
with recombinant IL-10 (Figure 5.4A and B). Importantly, LPS and PamC3SK4, TLR2 
and TLR4 ligands respectively, were able to induce IL-10 protein production by both B6 
and B6.SJL* BMMs (Figure 5.4C). Taken together, these data show that the IL-10 
pathway is likely intact in B6.SJL* mice.  
In order to establish the genetic basis of this phenotype, I decided to perform 
genetic analysis of B6.SJL* mice. I intercrossed B6.SJL* mice with B6 mice to generate 
F1 progeny (F1: first generation). Even if genetic, there could be contributions from the 
microbiota to this phenotype. For example, IL-10 deficient mice develop colitis that 
depends on the presence of Helicobacter spp. (66). The microbiota is thought to be 
acquired from the mothers, so I set up crosses with a B6.SJL* dam and a B6 sire, but 
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also crosses with a B6 dam and a B6.SJL* sire.  I removed the sires from the cages 
before or soon after birth of the pups, to ensure that I was able to trace the microbiota 
back to a B6 or a B6.SJL* dam. An autosomal recessive form of inheritance would 
predict that none of the F1 mice would present with this phenotype. An X-linked 
autosomal recessive mutation would predict that only F1 males born to B6.SJL* dams 
would exhibit this phenotype. Given the incomplete penetrance of this phenotype in 
B6.SJL* mice, interpretations about numbers or percentages of mice with a given 
phenotype become more complicated. Thus, in the X-linked recessive scenario, only 
some of the F1 males born to B6.SJL* dams would present the phenotype. Dominant 
forms of inheritance would predict that the phenotype would be present in the F1 
generation with similar prevalence as in B6.SJL* mice. Of course, this could be 
complicated by the fact that the microbiota could be a contributor. Consequently, I 
included F1 mice born to different dams as described above, and carried these separate 
lines of F1 mice into the second generation after sibling inbreeding F1 mice.  
Comparing 4 month-old F1 mice to age-matched B6 and B6.SJL* controls 
revealed that none of the 20 F1 mice analyzed so far presented this phenotype (Figure 
5.5A). Interestingly, analysis of Th1 cells in the blood may be sufficient to detect this 
phenotype, although the sensitivity was lower than in the spleen or mLNs (Figure 5.5B). 
Performing adoptive transfers and analysis of intestinal tissues is not feasible for such 
large numbers of mice, so I restricted my readouts to the abundance endogenous Th1 
cells. These results are so far consistent with an autosomal recessive form of 
inheritance.  
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Discussion: 
The phenotype observed in B6.SJL* mice is likely to be due to a mutation in a 
gene that impacts immune regulation in the intestine, and perhaps also systemic sites. 
This mutation can impact T cell responses to the microbiota in a T cell-extrinsic manner, 
given my results with adoptive transfers of A. muciniphila-specific T cells. The exuberant 
expansion of Amuc124 transferred T cells in B6.SJL* mice suggests that A. muciniphila 
becomes a major mucosal antigen in this particular context. While I still don’t know the 
mechanisms behind this phenotype, these striking observations would support the 
hypothesis that A. muciniphila is a major target of intestinal immune responses during 
inflammation. This effect could be mediated by its ability to take advantage of host-
mediated effector functions, such as neutrophil-induced epithelial hypoxia and 
production of Muc3 by epithelial cells (98). If so, understanding the role of responses to 
A. muciniphila in contexts of inflammation and/or immune dysregulation could shed light 
into the pathogenesis of IBD.  
Importantly, the observed T cell expansion in B6.SJL* mice occurs upon 
adoptive transfer. It remains possible that endogenous responses to A. muciniphila and 
other commensals don’t mirror these striking results. The large accumulation of 
transferred T cells likely result from the mutation in an immunoregulatory gene, since 
the same effect is not observed in B6 mice. However, the slightly larger precursor 
frequency of transferred T cells, as well as the “acute” nature of a T cell transfer may 
constitute artifacts that contribute to this striking expansion observed at the 12-day 
timepoint. Thus, it will be important to analyze the endogenous A. muciniphila-specific T 
cell populations in these mice.   
The hypothesis that this phenotype is a result of different microbiota composition 
between B6 and B6.SJL* mice is not supported by the data: neither cohousing or fecal 
microbiota transplant were able to transfer the phenotype. Thus, I designed experiments 
to establish a genetic basis. The results from the F1 cohort suggest that an autosomal-
recessive mutation is responsible. I have established crosses between F1 mice, 
keeping the two F1 mouse lines separate (B6 or B6.SJL* dam), and will analyze F2 
progeny once they reach the appropriate age where the phenotype is prevalent enough 
to detect. An autosomal recessive mode of inheritance would predict that 25% of the F2 
progeny would present this phenotype. An X-linked recessive mode of inheritance is not 
supported by my F1 data (see above). 
B6 and B6.SJL mice have been diverging for more than 55 generations at 
Jackson laboratories, plus an additional 10-20 generations at UC Berkeley since they 
were obtained in the lab. Before arriving at Jackson labs, SJL mice were backcrossed to 
B6 mice for 22 generations to generate the congenic B6.SJL strain. Thus, there may be 
additional polymorphisms between B6 and B6.SJL* mice that are unrelated to the 
causative mutation for this phenotype. Once I have identified F2 mice that present with 
increased Th1 cells and thus presumably carry the mutation, I will perform whole 
genome sequencing of >5 mice. Bulk segregate analysis (128) will allow me to identify 
the causative mutations from other segregating polymorphisms in B6.SJL* mice: any 
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polymorphism that is fixed in every single F2 mouse that presents this phenotype is a 
likely candidate for the causative mutation, while any irrelevant polymorphisms between 
B6 and B6.SJL* mice will segregate randomly in my F2 crosses, and their chance of 
being homozygous in every single F2 mouse that presents this phenotype will be very 
small. For this analysis, higher number of sequenced mice will increase my statistical 
power to identify the causative mutation.  
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Methods: 
Animals: 
Mice were housed under specific-pathogen-free (SPF) or gnotobiotic conditions 
at UC Berkeley. Mice were analyzed between 2.5 and 4.5 months of age. 4 months of 
age was selected as a minimum age to analyze F1 and F2 mice (Figure 5.5). C57BL/6J 
mice were used as wild-type mice. B6.SJL* mice consist of congenic C57BL/6J.SJL 
(B6.SJL-Ptprca Pepcb/BoyJ) mice housed at UC Berkeley for several years (at least 
since early 2010s).  
For experiments with Ex Germ-free mice, germ-free  mice were removed from 
their isolators and gavaged with 0.2mL NaHCO3 5-10% w/v to neutralize stomach acid .  
Intestinal contents from B6 or B6.SJL* mice were collected in PBS, homogenized 
mechanically, filtered through a 40um filter and 0.3mL were gavaged into germ-free 
mice. Germ-free mice were subsequently housed under SPF conditions at UC Berkeley.  
Cell isolation: 
Cells from mesenteric lymph nodes, Peyer’s patches (including cecal patch), 
spleen and thymus were isolated by mechanical dissociation on a 70-µm filter. Cells 
from small intestine lamina propria (after removal of Peyer’s patches) and large intestine 
lamina propria (cecum and colon, after removal of cecal patch) were cut longitudinally 
after removing excess adipose tissue, washed in PBS and incubated at 37ºC for 20 min 
with stirring in Hank’s balanced salt solution (HBSS) with 1 mM DTT, 10% (v/v) FBS, 
penicillin–streptomycin and HEPES. Intestines were then incubated at 37ºC for 25 min 
with stirring in HBSS with 1.3 mM EDTA, penicillin–streptomycin and HEPES, with 
further dissociation of epithelial cells in 10 mL PBS by shaking. Tissues were digested 
in RPMI with collagenase VIII (1 mg/mL, Sigma), DNaseI (5 µg/mL, Sigma), penicillin–
streptomycin and HEPES for 45 min, and lymphocytes were collected at the interface of 
a 44%/67% Percoll gradient (GE Healthcare).  
Cells from the blood were collected into 500uL PBS with heparin, washed in 
PBS and resuspended in ACK red blood cell lysis buffer. After two rounds of ACK lysis, 
cells were resuspended in PBS.  
T cell adoptive transfers: 
Peripheral lymph nodes and spleen of A. muciniphila-negative Amuc124 TCR 
transgenic Thy1.1 mice were dissociated mechanically on a 70-µm filter. Naïve CD4 T 
cells (CD3+ CD4+ CD62L+ CD44lo) were sorted on a BD FACSAria Fusion cell sorter 
and 10,000 cells were transferred by retro-orbital injection into recipient mice (Thy1.2). 
Recipient mice were analyzed 12 days post adoptive T cell transfer.  
Flow cytometry and sorting: 
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Cells were isolated as described above and stained in a 96-well U-bottom plate. 
Dead cells were excluded with a fixable Near-IR or Aqua live/dead dye (Life 
technologies) in PBS. Surface staining was performed in PBS with 2% FBS (v/v), 1 mM 
EDTA and 0.1% NaN3 for 30 min at 4ºC, or for 1 h at room temperature (RT) when 
staining for CXCR5 (no NaN3). Staining with tetramers was performed for 30’ at 37C in 
the presence of 50 nM Dasatinib (Sigma), followed by an additional 30’ at RT. Anti-
CXCR5 antibodies were included in this tetramer staining step, and the rest of surface 
staining was performed in a subsequent step for 30’ at 4˚C. Intracellular transcription 
factor staining (eBioscience buffer set, ThermoFisher) was performed by fixation for 1 h 
at RT and staining for 40 min at RT. Samples were analyzed on a BD LSR Fortessa or 
a BD LSR Fortessa X-20. The list of antibodies used can be found in Table S1.  
Stimulation of Bone marrow-derived macrophages (BMMs): 
Femur and tibias from B6 or B6.SJL* mice were harvested, washed in ethanol 
and smashed with mortar and pestle in RPMI-5 (RPMI with 5%  v/v Fetal bovine serum, 
L-glutamine,  HEPES and penicillin/streptomycin (Invitrogen)). Bone marrow samples 
were treated with ACK buffer to lyse red blood cells, and plated on 15cm non-tissue 
culture-treated plates in RPMI-10 with M-CSF. At Day 3 the media was changed, and at 
day 7 cells were scraped with cold PBS and replated in RPMI-10 onto 96-well plates 
with 100,000 cells/well and left overnight in the 37C incubator. The next day, cells were 
stimulated with recombinant mouse IL-10 (Tonbo), Lipopolysaccharide (Invitrogen) or 
PamC3SK4 (Invitrogen).  
Measurement of cytokine production by stimulated BMMs:  
IL-10 cytokine production was measured in the supernatants with a Cytometric 
Bead Array (BD 552364) according to manufacturer’s instructions. 
Detection of STAT3 Y705 phosphorylation by flow cytometry: 
BMMs were stimulated with recombinant mouse IL-10 (Tonbo) for 10-15 
minutes in RPMI-10 at 37C. PFA was added at 1.6% final concentration to immediately 
fix the samples, and samples were incubated at room temperature for 10-15 minutes. 
Samples were pelleted, resuspended in ice-cold methanol and incubated overnight at -
20C. Samples were washed and resuspended in FACS buffer with Fc Block and 
pSTAT3-Y705 antibody (clone 13A3).  
Quantification and statistical analysis: 
 Statistical tests were performed as indicated on the figure legends with 
Prism 8 software (Graphpad Prism). 
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Figures: 
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Figure 5.1: Exuberant activation and expansion of Amuc124 T cells in B6.SJL* 
mice 
(A) Representative FACS plots depicting transferred Amuc124 T cells (Thy1.1+) as a 
percentage of all CD4 T cells in B6 (Wild-Type) and B6.SJL* mice. (left) and 
transcription factor expression in B6.SJL* mice (right) in the SILP 12 days post adoptive 
transfer. 
(B) Frequencies of transferred T cells as percentage of all CD4+ T cells in intestinal 
tissues of B6 and B6.SJ* mice (n=5 mice per group) 12 days post adoptive transfer. 
Data are representative of three independent experiments. 
(C) Frequencies of transferred T cells as percentage of all CD4+ T cells in intestinal 
tissues of B6 mice, B6 mice cohoused with B6.SJ* mice, and B6.SJL* mice (Also 
cohoused with B6 mice) 12 days post adoptive transfer. n=3-4 mice per group. 
(D) Expression of TH1 (T-bet+ FOXP3–), TH2 (GATA3+ FOXP3–), TH17 (RORgt+ FOXP3–
), Treg (FOXP3+) or TFH (Bcl6+ PD-1+) markers by transferred T cells in intestinal tissues 
of B6, B6 cohoused with B6.SJL* or B6.SJL* mice (cohoused with B6) 
Each symbol represents a mouse, error bars represent mean ± SD. p-values were 
calculated with unpaired Student’s t-tests (D). 
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Figure 5.2: B6.SJL* mice induce aberrant Th1 responses 
(A) Representative FACS plots depicting TH1 (T-bet+ FOXP3–) CD4+ T cells in the 
spleens and mLNs of B6 and B6.SJL* mice.  
(B) Frequencies of TH1 (T-bet+ FOXP3–) as percentage of all CD4+ T cells in the spleens 
and mLNs of B6 and B6.SJL* mice. Data are representative of five independent 
experiments. 
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(C) Frequencies of TH1 (T-bet+ FOXP3–) as percentage of all live cells in the mLNs of B6 
and B6.SJL* mice. Data are shown for five independent experiments. 
Each symbol represents a mouse, error bars represent mean ± SD. p-values were 
calculated with unpaired Student’s t-tests. 
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Figure 5.3: Fecal microbiota transplant into Germ-free mice fails to transfer the 
B6.SJL* phenotype 
(A) Experimental design of fecal microbiota transplants into Germ-free (GF) mice. 
Intestinal contents from B6 or B6.SJL* mice were orally gavaged into GF mice. After 30 
days (repeat 1) or 60 days (repeat 2), 10,000 naïve Amuc124 TCR transgenic T cells 
were transferred and analyzed 12 days later.   
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(B) Frequencies of transferred T cells as percentage of all CD4+ T cells in intestinal 
tissues of B6 and B6.SJL* mice (n=4 mice per group) 12 days post adoptive transfer. 
Data are representative of two independent experiments. 
(C) Frequencies of TH1 (T-bet+ FOXP3–) as percentage of all live cells in the mLNs of B6 
and B6.SJL* mice. n=4 mice per group, data are representative of two independent 
experiments. 
Each symbol represents a mouse, error bars represent mean ± SD. p-values were 
calculated with unpaired Student’s t-tests. 
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Figure 5.4: Cells derived from B6.SJL* mice are able to produce IL-10 and 
respond to IL-10 stimulation 
(A) Representative FACS plots depicting STAT3 phosphorylation (Y705) upon 
stimulation of bone marrow-derived macrophages (BMMs) from B6 and B6.SJL* mice 
with recombinant mouse IL-10 (rIL-10)    
(B) Frequencies of B6 and B6.SJL* BMMs with phosphorylated STAT3 (Y705) upon 
stimulation with mouse rIL-10. n=3 samples, each with BMMs from a different mouse. 
(C) Production of IL-10 by B6 and B6.SJL* BMMs upon Pam3CSK4 or 
lipopolysaccharide (LPS) stimulation, as measured by CBA analysis. n=3 samples, each 
with BMMs from a different mouse. 
Error bars represent mean ± SD.  
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Figure 5.5: Genetic analysis of the B6.SJL* phenotype 
(A) Percentage of CD4+ T cells expressing Th1 markers (T-bet+ FOXP3–) in 4 month old 
F1 mice derived from crossing B6.SJL* and C57BL/6J mice. F1 mice born to a B6 dam 
(red) or a B6.SJL* dam (brown) were kept separately.  
(B) Percentage of CD4+ T cells expressing Th1 markers (T-bet+ FOXP3–) in the blood of 
B6 and B6.SJL* mice (same mice as in (A) a week earlier).  
Error bars represent mean ± SD. p-values were calculated with one-way ANOVA with 
Sidak correction for multiple comparisons (A) or a Mann-Whitney test (B).  
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Chapter 6: Concluding remarks 
Homeostatic adaptive immune responses to the microbiota are emerging as key 
players in the interaction between commensal microbes and the host (12). In the gut, 
select known commensal bacteria induce T-dependent antibodies and cognate T cell 
responses during homeostasis (22, 59, 65), while the majority of other commensal 
species are targeted by T-independent mechanisms (36). Dysregulation of antibody and 
T cell responses to the intestinal microbiota lead to inflammation and Inflammatory 
bowel diseases (15, 75). Thus, understanding which commensal bacteria induce 
cognate adaptive responses and unveiling the signals and cell types involved in their 
induction and regulation remain key important questions. These questions, if answered, 
would shed light into basic mechanisms of host-microbiota symbiosis and the etiology of 
IBD.  
Despite the large abundance of foreign antigens and frequencies of activated 
lymphocytes present in the intestine, very few commensal bacteria have been identified 
that induce cognate T cell and B cell responses during homeostasis. One possibility is 
that adaptive responses to commensals are limited to select immunostimulatory 
bacteria that exhibit certain functions, such as occupation of an epithelial-associated 
niche, interactions with epithelial cells, sampling through particular routes etc. If so, 
identifying these bacteria and characterizing cognate adaptive immune responses 
would be of utmost importance to the field. This first scenario is supported by the fact 
that existing examples of T cell-inducing intestinal bacteria are limited to a pathobiont, 
Helicobacter spp., and Segmented filamentous bacteria (SFB), an immunostimulatory 
commensal which burrows itself into epithelial cells and induces a robust Th17 
response. 
Another possibility is that a large fraction of commensal bacteria is targeted by 
cognate adaptive immune responses, but that only a few examples have been identified 
so far. This second scenario is not supported by the existing data comparing IgA-Seq in 
T cell-deficient and  -sufficient mice (35), although this approach cannot identify bacteria 
that are highly bound by both TI and TD IgA. My IgG1-seq results identify only a few 
bacteria that induce T-dependent IgG1, which would not support this second scenario.  
However, even if only select commensal bacteria are recognized by the 
adaptive immune system during homeostasis, it is unlikely that these responses are 
limited to SFB and Helicobacter spp. In fact, other intestinal bacteria from humans are 
sufficient to induce intestinal Th17 cells in the intestine in a gnotobiotic setting (129), 
although the antigen-specificity wasn’t explored. Thus, identifying novel commensal 
bacteria that induce cognate adaptive immune responses during homeostasis remains 
an important task.  
Here I have identified A. muciniphila as a commensal microbe that induces T-
dependent IgG1 and IgA antibody responses as well as cognate intestinal T cell 
responses during homeostasis. The results from the IgG1-sequencing experiments 
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show that a few other commensal bacteria, such as a specific species within the 
Muribaculaceae family (also named Bacteroides S24-7), induce similar TD antibody 
responses. These high affinity local (IgA) and systemic (IgG1) antibody responses 
against A. muciniphila and Muribaculaceae spp. are likely to contribute to the important 
roles attributed to commensal-specific antibodies, such as protection from gut-derived 
septicemia (42, 74) and education of the neonatal immune system (41, 72). However, 
they may also contribute to disease pathogenesis in genetically susceptible people and 
mice through engagement of activating Fc receptors (75).  
Interestingly, antibody and T cell responses to A. muciniphila were variable 
across SPF mice. These results suggest that there may be complex interactions with 
other commensal microbes present in the intestine, such as competition for a particular 
niche, alteration of the function of A. muciniphila based on the presence of other 
commensals, existence of bystander signals arising from other commensals etc. 
However, A. muciniphila was sufficient to induce cognate high affinity IgG1 and IgA 
antibodies in gnotobiotic mice colonized with the ASF microbiota. In this setting, T cell 
responses to A. muciniphila were also very reproducible and consisted of T follicular 
helper cells in the Peyer’s patches. These results show that A. muciniphila engages the 
immune system directly, is sampled during homeostasis, and induces cognate adaptive 
immune responses. 
 T cell immunity to A. muciniphila was different than T cell responses to SFB or 
Helicobacter spp. A. muciniphila is the first example of a commensal bacterium that 
induces a response largely dominated by TFH cells, with the absence of other T effector 
fates. Surprisingly, T cell immunity to A. muciniphila changed in the context of a 
conventional microbiota: adoptive transfers into SPF mice led to induction of A. 
muciniphila-specific Th1, Th17 and Treg responses that homed to the small intestine 
and large intestine lamina propria. Importantly, T cell skewing varied across mice and 
experiments. These results are consistent with the variable IgG1 and IgA antibody 
responses observed in SPF mice, and argue that responses to this commensal 
bacterium can be altered depending on contextual signals. Whether this is a general 
feature of commensal-specific T cell responses or a feature specific to A. muciniphila 
remains to be determined, since the other two examples of cognate T cell responses to 
a commensal do not exhibit this variability: T cell responses to SFB consist of Th17 both 
in monocolonized and SPF settings, and Helicobacter spp. induce RORgt+ FOXP3+ Treg 
cells in SPF mice.  
Importantly, A. muciniphila is associated with protective effects in metabolic 
disease and in PD-1 cancer immunotherapy (92, 93, 100), among others. The 
mechanisms for these effects on host physiology remain elusive, but these effects 
involved IFNg and type-I immunity to A. muciniphila, respectively. In fact, protection from 
cancer immunotherapy in people correlated with peripheral Th1 cell responses to A. 
muciniphila antigens. My work provides a potential explanation for this correlation: if T 
cell immunity to A. muciniphila is similarly variable in humans, then perhaps only 
  
 
76  
patients with pre-existing Th1 immunity to this bacterium will benefit from the protective 
effects of this commensal upon PD-1 cancer immunotherapy.  
While immune responses are likely to underlie many aspects of the interaction 
between these commensal bacteria and the host, other non-immune mechanisms 
should also be considered. Production of metabolites by commensal microbes is known 
to impact host physiology, such as induction of Treg cells (8–10) and colonization 
resistance (130), among others. T cell-inducing bacteria occupy niches that are in direct 
contact with host cells, and tend to be very abundant at these locations. Thus, 
metabolites derived from these commensal bacteria may preferentially impact host 
physiology locally but also at systemic sites. Indeed, A. muciniphila-derived 
nicotinamide has been shown to influence disease progression in mouse models of 
Amyotrophic Lateral Sclerosis (97).   
Finally, T cell immunity to A. muciniphila changes dramatically in a specific 
mouse line identified in my laboratory (B6.SJL* mice). This mouse line likely carries a 
mutation in an immunoregulatory gene that impacts immunity to this bacterium in a T 
cell-extrinsic manner. While the nature of the mutation remains to be determined, the 
exuberant responses observed in this mouse line suggest that A. muciniphila becomes 
a major mucosal antigen in the context of inflammation, which could be mediated by its 
ability to colonize the healing epithelial mucosa. This would suggest that adaptive 
immunity to A. muciniphila may play critical roles during infection, inflammation and 
disease.  
In summary, I have identified A. muciniphila as a novel commensal bacterium 
that induces antibody and T cell responses during homeostasis. Responses to A. 
muciniphila include TD IgG1 and IgA, as well as TFH cells but also other T helper fates 
in conventional mice. Immunity to A. muciniphila can be shaped by contextual signals, 
and may underlie some of the systemic effects of this bacterium. Finally, A. muciniphila 
may become a major mucosal antigen during inflammation. Much work remains to 
understand the interactions between this bacterium and the host: How is this bacterium 
sensed? Which antigen-presenting cells are involved in this response? Why does it elicit 
adaptive immune responses? Are there other commensal bacteria with similar 
responses? How do antibody and T cell responses to A. muciniphila impact 
homeostasis and disease? Do T cell responses to A. muciniphila mediate protection 
against metabolic disease or influence cancer immunotherapy? If so, what are the 
mechanisms? What is the nature of B6.SJL* mice, and what is the fate and role of A. 
muciniphila-specific T cells induced in the context of inflammation? These questions will 
undoubtedly be explored in future scientific inquiry.  
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